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ABSTRACT 
 
Bridgett L. Steele:  Total Internal Reflection Fluorescence Microscopy for Characterizing 
Biochemical Interactions 
(Under the Direction of Nancy L. Thompson) 
 
Total internal reflection fluorescence (TIRF) microscopy is a widely used 
technique for the study of biologically relevant processes both in vitro and in vivo.  In 
TIRF, an incident light beam propagates through a transparent solid and encounters a 
solid/liquid interface at an angle sufficient enough such that the light undergoes total 
internal reflection, which generates an evanescent field that decays exponentially with 
distance from the surface.  Thus, the main advantage of TIRF is that it selectively excites 
fluorescent molecules at or near the solid-solution interface.  TIRF is used to study the 
thermodynamic and kinetic properties of three systems in this dissertation.     
Pregnane X receptor (PXR) is a member of the nuclear receptor family of ligand 
activated transcriptional factors that regulate gene expression.  Using TIRF, the ligand-
dependent binding of PXR to the steroid receptor coactivator-1 (SRC-1) is studied in the 
presence of the known PXR activator, rifampicin.  In this system, the ligand binding 
domain of PXR is immobilized at the solid-solution interface, and fluorescently-labeled 
SRC-1 peptide in solution is used to mimic the full length SRC receptor.  By measuring 
the fluorescence intensity as a function of the solution concentration of fluorescently-
labeled SRC-1 at constant, increasing concentrations of rifampicin, four equilibrium 
binding constants are obtained, which illustrate the cyclic nature of these interactions.       
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Discoidin domain receptor 2 (DDR2) is a receptor tyrosine kinase that is activated 
by fibrillar collagens in the extracellular matrix.  Upon activation through collagen 
binding, DDR2 regulates cell adhesion, proliferation, and extracellular matrix 
remodeling.  To study the binding of the extracellular domain of DDR2 to collagen, 
methods to deposit thin films of aligned or unaligned collagen I on fused silica slides 
were developed.  Additionally, to characterize the effect of oligomerization of DDR2 on 
collagen binding, methods to separate monomeric, dimeric, and aggregates of DDR2 
were also explored.  This work represents the preliminary steps necessary to study the 
binding of surface immobilized collagen to fluorescently-labeled DDR2 using TIRF.     
A new method using through-prism total internal reflection fluorescence 
microscopy with continuous photobleaching (TIR-CP) is presented.  In this method, 
small structures, such as prokaryotic cells or isolated eukaryotic organelles, containing 
fluorescent molecules are adhered to a surface.  This surface is continuously illuminated 
by an evanescent wave created by total internal reflection.  The characteristic length 
describing the decay of the evanescent intensity with distance from the surface is smaller 
than the structures.  The fluorescence decay rate resulting from continuous evanescent 
illumination is monitored as a function of the excitation intensity.  The data at higher 
excitation intensities provide apparent translational diffusion coefficients for the 
fluorescent molecules within the structures because the decay results from two competing 
processes (the intrinsic photobleaching propensity and diffusion in the small structures).   
The theoretical basis for the technique is presented and the applicability of the technique 
is demonstrated by measuring the diffusion coefficient, 6.3 ± 1.1 µm2/sec, of green 
fluorescent protein (GFP) in Escherichia coli cells. 
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Chapter 1 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter reprinted with permission from Nature Publishing Group, 
Copyright 2007 from Thompson, NL and Steele, BL (2007) Total internal reflection 
fluorescence correlation spectroscopy. Nature Protocols 2:878-890.   
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1.1 Overview 
 Measuring the interactions between individual biological molecules in a regulated 
pathway is key to understanding the overall functioning observed in cellular systems.  
Total internal reflection fluorescence microscopy (TIRF) is a powerful method for 
quantitatively measuring equilibrium thermodynamic and kinetic constants in biological 
systems.  As such, this thesis presents work towards characterizing the molecular 
interactions of two biologically relevant systems, pregnane X receptor (PXR) and 
discoidin domain receptor 2 (DDR2), using TIRF microscopy, and presents a new TIRF 
method for studying protein diffusion in living cells.  PXR is a member of the nuclear 
receptor family of ligand activated transcriptional factors and is believed to be 
responsible for the metabolism of over 50% of prescription drugs.1  In Chapter 2, in vitro 
binding of PXR to one of its transcriptional co-activators, steroid receptor co-activator 1 
(SRC-1), in the presence of the antibiotic rifampicin is examined using TIRF.  DDR2 is a 
receptor tyrosine kinase that binds to collagens in the extracellular matrix (ECM), in turn 
leading to the upregulation of enzymes that degrade the ECM.2  In Chapter 3, work 
towards using TIRF to study the binding of the extracellular domain of DDR2 to collagen 
type I is explained.  Finally, a new method for studying diffusion of green fluorescent 
protein (GFP) in Escherichia coli through combination of TIRF with continuous 
photobleaching (CP) was developed and is described in Chapter 4.  The theoretical basis 
and practical applications of TIRF microscopy and combinatory techniques is presented 
in this chapter, along with brief descriptions of other methods used in this thesis.   
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1.2 Total internal reflection fluorescence microscopy (TIRF) 
 Total internal reflection fluorescence microscopy (TIRF) was first introduced as a 
sensitive method for measuring the biophysical interactions of surface associated 
fluorescent molecules in the 1980’s.3  Nearly thirty years after its inception, TIRF is 
commonly used to measure surface densities of bound, fluorescent molecules and to 
image cell–substrate contacts.4-6  TIRF is also used in conjunction with other techniques 
such as fluorescence recovery after photobleaching (FRAP), fluorescence resonance 
energy transfer (FRET), fluorescence correlation spectroscopy (FCS), and fluorescence 
polarization to measure surface binding kinetic rates and translational diffusion 
coefficients, molecular distance-dependent events, local fluorophore concentrations and 
translational mobilities, and population orientation distributions, respectively.4, 7  
Recently, TIRF has been combined with atomic force microscopy (AFM), and the 
combination has been shown to be a powerful technique for determining both the local 
structure and dynamics of biological molecules and assemblies.8, 9  
In TIRF, an incident light beam propagates through a transparent solid, 
encounters a solid-liquid interface at an angle greater than the critical angle, and 
undergoes total internal reflection.  The critical angle is defined as αc = sin-1(n2/n1), 
where n2 and n1 are the refractive indices of the solution and solid, respectively (n1 > n2).  
An electromagnetic field called the evanescent wave is created and propagates parallel to 
the surface.  The evanescent wave penetrates into the liquid medium, and the intensity 
decays exponentially with distance from the surface.  The characteristic 1/e decay depth 
is defined by the equation d = λ0/[4pi(n12sin2α-n22)1/2], where λ0 is the wavelength of light 
in a vacuum, and α > αc is the incidence angle measured from the perpendicular to the 
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interface (Figure 1.1).  The primary advantage of using evanescent illumination is that it 
selectively excites fluorescently labeled molecules at the surface-solution interface, even 
while they are in reversible equilibrium with the solution.4, 7  For live cells immobilized 
at the solid-solution interface, only fluorophores located within or close to the plasma 
membrane are excited, which significantly reduces background fluorescence.6  TIRF 
measurements are most commonly carried out on a fluorescence microscope but can also 
be performed in a conventional spectrofluorimeter adapted for evanescent excitation.7, 10  
Additionally, the use of microfluidics with fluorescence microscopy would allow for the 
automation of TIRF measurements.11  
 For fluorescence microscopy, the conventional method for generating TIR to date 
has been to use a prism, mounted to the stage of an inverted fluorescence microscope, 
through which a laser beam is loosely focused at the point of internal reflection. The 
prism is optically coupled, generally by using a refractive index matching liquid such as 
glycerol, to the surface of interest.  A surface, solution and coverslip sandwich is formed 
using spacers.  The evanescently excited fluorescence is collected with a microscope 
objective and is passed through a barrier filter (and usually a dichroic mirror) in the 
microscope to remove scattered radiation from the excitation source.  The light is passed 
to a detector, which is typically a silicon avalanche photodiode or a photomultiplier.  For 
some combinatorial TIRF techniques, a circular pinhole between 50 and 200 µm in 
diameter is placed in a confocal back-image plane to limit the area from which the 
fluorescence is collected before passing to the detector (Figure 1.2a).  Alternatively, an 
optical fiber can be used in the same manner as a pinhole to limit the amount of light that 
reaches the detector.12-15 
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 A second method for generating an evanescent field along a surface of interest is 
to use through-objective TIRF.  As the name implies, internal reflection is generated by 
focusing a laser beam through the periphery of a high numerical aperture objective, 
which is directly coupled to the surface of interest, in a manner similar to epi-illumination 
(see section 1.3). The evanescently excited fluorescence is collected back through the 
same objective, passes through a dichroic mirror and barrier filter to remove scattered 
excitation light and is passed through a pinhole to the detector (Figure 1.2b).  Additional 
focusing lenses may also be required to direct the light source through the objective at an 
angle great enough for TIRF.  Recent work details the building and testing of in-house 
through-objective TIRF systems.4, 12-14  Additionally, several manufacturers provide TIRF 
attachments for inverted microscopes; thus, through-objective TIRF is becoming the 
predominant configuration.  
Three advantages of through-prism TIRF are the versatility of optical alignment, a 
lower background signal arising from the fact that the incident beam does not enter the 
interior of the microscope and (in many cases) lower cost.  This geometry is also readily 
amenable to constructing evanescent interference patterns15 and to the use of very high 
refractive index substrates.16  Advantages of through-objective TIRF include sample-top 
accessibility, although through-prism configurations allowing such accessibility have also 
been designed,17 decreased stray laser radiation in regions exterior to the microscope 
owing to the enclosed nature of the system, and the fact that slightly more fluorescence is 
collected through the higher refractive index side of the interface compared with the 
lower index side.18  Also, through-objective TIRF often gives a slightly better image 
quality owing to proper matching of the objective with the coverslip and sample plane.  
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Theoretical treatments for the optical characteristics of the evanescent wave for both 
geometries have been presented.19-21 
In TIRF, equilibrium constants are found by measuring the evanescently excited 
fluorescence intensity as a function of the bulk concentration of fluorescently labeled 
molecules in solution.  The resulting signal arises from two sources—from fluorescently 
labeled molecules that bind to the surface and from fluorescently labeled molecules that 
are not associated with the surface but diffuse within the evanescent wave.  The latter 
creates a background signal that increases linearly with the bulk concentration of 
fluorophores in solution, therefore requiring the use of negative controls to account for 
this phenomenon.  Negative controls are created either by removing surface binding sites 
or by blocking binding to the surface.  The background signal is then subtracted from the 
original curve before obtaining the equilibrium binding constant (Figure 1.3).22      
While equilibrium binding constants can be directly measured with TIRF, 
measuring kinetic rates for biological systems requires conjunction with other techniques, 
such as FCS or FRAP.  In TIR-FRAP, a high powered laser beam is used to rapidly 
bleach fluorescent molecules that are in equilibrium at the solid-solution interface.  After 
bleaching, a low power beam is then used to monitor fluorescence recovery, which arises 
as photobleached molecules at the solid-solution interface desorb from the surface and 
are replaced with unbleached molecules from the solution or that diffuse from 
surrounding, non-illuminated surface areas.  The rate and shape of the fluorescence 
recovery contains information about the surface association and dissociation rate 
constants, diffusion coefficients on the surface, and solution diffusion coefficients (Figure 
1.4).  TIR-FRAP has been used in vitro to examine protein binding to phospholipid 
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bilayers and has been used in live cell work to monitor kinetic rates for the interactions of 
intracellular and extracellular proteins with the plasma membrane.5  When used in 
combination with an imaging detector, spatial maps of dissociation rates from intact cell 
membranes for a fluorescent molecule can be generated and used to probe surface 
inhomogeneity in cells.23 
In FCS, temporal fluctuations in fluorescence are correlated to obtain information 
about the processes giving rise to the observed fluctuations, when the number of 
molecules in the observation volume is small.  The fluctuations typically arise from 
molecules diffusing into and out of the observation region or from molecules undergoing 
transitions between different fluorescent states.  FCS is commonly used to measure 
equilibrium binding constants, diffusion coefficients, kinetic rate constants and 
oligomerization.24-26  In combination, TIR-FCS is a tool for elucidating events that occur 
at or very close to surface-solution interfaces, such as the kinetic rate constants that 
describe the reversible association of fluorophores with the interface, local fluorophore 
concentrations and local translational mobilities.7, 27  These parameters can be extracted 
from the magnitude and the rate and shape of the decay of the normalized fluorescence 
fluctuation autocorrelation function G(t).28-32  While TIR-FRAP is useful for measuring 
kinetic rates in systems with characteristic off rates on the order of 1 sec to 30 min, TIR-
FCS requires faster characteristic rates, on the order of 1 ms to 1 sec, to generate 
correlation functions with adequate signal to noise ratios.  It should be noted that the 
characteristic time range for each technique is limited by instrumental and software time 
resolution and may vary for different instrumental set-ups. 
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In recent years, the commercialization of through-objective TIRF microscopes, 
combined with improvements in data acquisition rates in electron-multiplying charge 
coupled device (EM-CCD) cameras, has lead to a rapid rise in use of TIRF in single-
molecule detection and imaging in vivo of dynamic membrane processes.  The 
advantages of imaging with TIRF include improved background as compared to 
traditional fluorescence microscopy, precise axial tracking, applicability to multi-color 
and multi-photon excitation, and the ability to image cells longer due to higher survival 
rates achieved by using low excitation intensities.4, 6  Furthermore, TIRF has been shown 
to be compatible with standard epifluorescence, bright field, dark field, or phase contrast 
illumination and can be switched back and forth to obtain more information about the 
biological systems under study.  Unlike confocal microscopy, TIRF lacks the ability to 
probe deep within thick cells, but will likely continue to grow in popularity due to its 
ability to be adapted to standard microscope optics.4 
 
1.3 Epifluorescence Microscopy 
 Epifluoresence refers to a general technique for stimulating and collecting 
fluorescence of a sample using the same lens.  For epi-illumination, a light source is 
reflected off a dichroic mirror through a microscope objective which focuses the light 
into a spot on the sample.  The emitted fluorescence is then collected back through the 
same objective, is passed through the dichroic mirror to a barrier filter that allows only 
selected wavelengths of light to pass, and is reflected onto a detector, typically a CCD 
camera (Figure 1.5).  Reflected excitation light that is collected by the objective will not 
be transmitted through the dichroic mirror and barrier filter.  Epifluorescence is 
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commonly used for imaging of biological samples labeled with fluorescent dyes and is 
the illumination method used in wide field, through-objective TIRF, and confocal 
fluorescence imaging.  Epifluorescence is used in Chapter 3 to image collagen films on 
fused-silica substrates.  
 
1.4 Continuous Photobleaching  
 Continuous photobleaching (CP) was first developed in the 1980’s as alternative 
method to FRAP for studying the translation diffusion of lipids in model systems and live 
cells.  In CP, an excitation source is used to bleach fluorescence molecules in a sample, 
and the fluorescence decay is monitored as a function of time.  The rate and the shape of 
the fluorescence decay can then be analyzed to extract diffusion coefficients for 
biological samples.  As high powered laser flashes and detector protection intervals are 
not required for CP, the instrumental set-up is also less complicated than for FRAP.  
However, there is a higher probability of photochemical effects occurring in CP, since the  
intensity used to excite and bleach fluorophores in CP is higher than the intensity used to 
monitor fluorescence recovery in FRAP, and data interpretation can be complicated.33, 34  
A novel method that combines CP with TIR, which allows for diffusion to be measured 
in structures only slightly larger than optical resolution, is described in chapter 4.35  
 
1.5 Atomic Force Microscopy 
 Atomic force microscopy (AFM) is a scanning probe technique, which was 
invented in 1986,36 that is used to study nonconductive, soft, and live biological samples.  
AFM is used to image surface topography of samples and to measure intermolecular and 
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intramolecular forces between interacting molecules.37-40    In imaging AFM, a sharp tip 
(typically made of silicon or silicon nitride), which is attached to a spring loaded 
cantilever, is rastered across the surface of sample.  Interactions with features on the 
surface cause the tip to move up or down with the contour of the surface and are detected 
using a laser beam, which is reflected off the back of the cantilever and onto a position 
sensitive photodiode.  A piezoelectric tube connected to a feedback mechanism is used to 
translate the sample in the X, Y, and Z directions (Figure 1.6).  An image of the surface is 
then generated by plotting Z direction movements as a function of X-Y positions.39, 40  
The spatial resolution of the measurements is related to the radius of curvature of the tip 
apex, which is minimized (typically 2 to 50 nm) for best resolution.40  AFM can be 
conducted in air, aqueous solution, or under vacuum.  Due to its widespread use, many 
AFM scanning techniques have been developed,40 and the two most commonly used 
modes are contact and intermittent-contact or tapping mode.   
AFM is a powerful tool for probing biological systems either in air, under near 
physiological conditions, or on live cells and has been used to study biological systems 
from the single molecule to cellular level.  AFM is advantageous in that biological 
samples can be studied in buffered solutions at ambient temperature without the need for 
fixing, staining, or labeling of samples.37, 38  For biomembranes imaged in aqueous 
environments, lateral resolution on the order of several nanometers and height resolution 
of 0.1 nm have been achieved with image acquisition on the order of 1 minute.  However, 
if biological molecules are flexible or are loosely attached to the surface of interest, the 
AFM tip can act as a “molecular broom,” sweeping aside biological components as it 
scans the surface, potentially damaging the sample.  To overcome this limitation, tapping 
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mode is commonly used as it exerts lower forces on the sample.37  In tapping mode, the 
cantilever is oscillated by an additional piezo such that the tip intermittently touches or 
taps the surface, instead of continuously being in hard contact with the surface as in 
contact mode.40  Traditionally, AFM has also suffered from slow acquisition times, which 
prevented real time monitoring of biological processes and observation of events that 
occur on the millisecond time scale,39 but in recent years AFM microscopes with video 
rate imaging have been introduced.41, 42  AFM is used in Chapter 3 to image collagen 
films on glass substrates. 
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Figure 1.1 Total Internal Reflection.  (a) Total internal reflection is generated when 
an incident light beam propagates through a transparent solid and encounters a planar 
solid-solution interface at an angle greater than the critical angle αc, creating an 
electromagnetic field that excites fluorescent molecules near the solid-solution 
interface (green circles).  The evanescent wave decays exponentially with distance d 
(shown in blue) from the surface, and fluorescent molecules outside of this field are 
not excited (clear circles).  For fused silica and glass, n1≈1.5, n2≈1.3 and d≈0.1 µm. (b) 
For through-prism TIR, if the laser beam is loosely focused at the point of internal 
reflection, the resulting evanescent field along the surface has an elliptical Gaussian 
shape.  
13  
 
 
microscope
detector
laser
PC
correlator
shutter
BF
pinhole
eye
mirror
DCM
detector
laser
PC
correlator
microscope
prism
shutter
BF
pinhole
eye
mirror
a
i
b
i
ii ii
stage
objective
focal plane
dichroic
mirror
surface of
interest
oil
λ0
sample
sample dish
spacer/sealant
objective
focal plane
coverslip
oil
sample
surface 
of interest
stage
prism
glycerol
λ0
 
Figure 1.2 TIRF Apparatus.  (a) Through-Prism TIRF.  (i) A laser beam is totally internally 
reflected into a sample through a prism that is mounted onto the stage of an inverted microscope.  The 
evanescently excited fluorescence is collected through a microscope objective and passed through a 
barrier filter (BF) to remove scattered evanescent light.  The light is passed through a circular pinhole 
(optional), which is placed in a confocal back-image plane, before reaching the detector.  The resulting 
signal is processed using a PC with an optional correlator card.  (ii) The sample is composed of a 
transparent planar substrate of interest, solution and coverslip sandwich separated by spacers, and is 
mounted onto an inverted microscope such that the prism is optically coupled with glycerol to the 
substrate (usually fused silica).  Internal reflection is generated by focusing a laser beam through the 
prism onto the sample and the evanescently excited fluorescence is collected through the objective.  (b) 
Through-objective TIRF.  (i) A laser beam is directed through the microscope, reflected upwards using 
a dichroic mirror (DCM) and focused through the periphery of a high numerical aperture objective, 
which is directly coupled to the surface of interest, to generate internal reflection.  The evanescently 
excited fluorescence is collected back through the same objective, passes through a barrier filter (BF) to 
remove excitation light and passes through a pinhole (optional) before reaching the detector.  The 
resulting signal is acquired using a PC.  (ii) The transparent planar substrate of interest is coupled to a 
high numerical aperture objective using immersion oil.  Total internal reflection is generated by 
focusing the laser through the periphery of a high numerical objective onto the substrate and the 
evanescently excited fluorescence is collected back through the objective and filter as described b(i). 
14  
 
 
 
KA (unitless)
0 1 2 3 4
Fl
u
o
re
sc
e
n
ce
 
(ar
bi
tra
ry
 
u
n
its
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
F(+)
F(-)
KA (unitless)
0 1 2 3 4
Fl
u
o
re
sc
en
ce
 
(ar
bi
tra
ry
 
u
n
its
)
0.0
0.2
0.4
0.6
0.8
1.0
F(+) - F(-)
334.12 =n
n1 
n2 
d 
z 
334.12 =n
n1 
n2 
d 
z 
Concen ration Concen ration 
a 
d 
b 
c 
Figure 1.3 Equilibrium Binding Measured with TIRF.  (a) Fluorophores (clear and 
green circles) are in equilibrium between surface binding sites and solution.  
Fluorophores within the evanescent wave, which are diffusing near the surface or are 
bound to the surface, are evanescently excited (green circles) and give rise to a signal, 
F(+).  (b) Negative controls are generated by removing the surface binding sites.  
Therefore, the resulting evanescently excited fluorescence, F(-), arises only from 
fluorophores that are not surface associated, but are diffusing within the evanescent 
wave.  (c) The fluorescence intensities for F(+) and F(-) are plotted as a function of the 
bulk concentration of fluorescent molecules in solution, and (d) F(-) is subtracted from 
F(+) to obtain an accurate equilibrium binding constant for the surface-associated 
binding.    
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Figure 1.4 TIR-FRAP.  In TIR-FRAP, (a) before bleaching (t<0), fluorescent 
molecules (green and clear circles) are in equilibrium between surface binding sites 
and the solution, and those at or near the surface are evanescently excited (green 
circles), giving rise to a fluorescence signal.  (b)  At t=0, a short, high intensity laser 
pulse is applied to the sample such that a fraction of the surface-associated fluorescent 
molecules within the evanescent wave are irreversibly photobleached (gray circles), 
reducing the fluorescence signal. (c) At t>0, surface-associated, photobleached 
molecules begin to desorb from the surface and are replaced with unbleached 
fluorophores from solution or from the surrounding non-illuminated area, and the 
fluorescence signal begins to recover. (d) By fitting the fluorescence recovery curve to 
appropriate theoretical forms, information about the surface association and 
dissociation constants and diffusion coefficients on the surface can be obtained from 
the rate and shape of the curve.     
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Figure 1.5 Epifluorescence Illumination.  In epi-illumination, excitation light (blue) 
is passed through a microscope port, reflected off a dichroic mirror through an 
objective which focuses the light onto a sample, giving rise to fluorescence (green).  
The emitted fluorescence is then collected through the objective and passes through 
the dichroic mirror and barrier filter, which removes reflected and scattered excitation 
light, to an imaging detector.   
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Figure 1.6 AFM Apparatus.  In AFM, a silicon or silicon nitride tip attached to a 
cantilever is rastered over the surface of a sample and encounters surface features that 
cause deflections of the tip.  These deflections are monitored using a laser beam that is 
reflected off the cantilever onto a position-sensitive photodiode.  A feedback loop 
from the detector keeps either the force between the sample and the tip constant or the 
distance between the tip and the sample constant, by changing the Z position of the 
surface or tip, using a piezoelectric (PZT) scanner, which also controls the X and Y 
positions. (Image released to Public Domain, 2008) 
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Chapter 2 
 
Quantitative Studies of the Ligand-Dependent Binding of  Pregnane X  
 
Receptor to Steroid Receptor Coactivator 1 
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2.1 Introduction 
 Pregnane X receptor is a member of the nuclear receptor (NR) family of ligand 
activated transcription factors that regulate gene expression.  These receptors bind to 
DNA, recruit transcriptional coregulators in a ligand dependent manner, and activate the 
production of proteins that metabolize exogenous (xenobiotic) and endogenous 
chemicals.43-45  Unlike many other nuclear receptors that bind with high specificity to a 
particular set of ligands, PXR is a promiscuous receptor that binds to ligands of various 
sizes, ranging from 200 to 800 Da, with a wide array of structural diversity, including 
prescription drugs, herbal medicines, dietary supplements, environmental pollutants, and 
endobiotics.46, 47  Upon activation through ligand binding, PXR induces the expression of 
gene products involved in the uptake, metabolism, and elimination of xenobiotic and 
endobiotic compounds.45, 48   
PXR regulates genes involved in all phases of drug metabolism, including the 
cytochromes P450 (CYP450s), heme-containing monooxygenases involved in phase I 
metabolism; phase II enzymes such as glutathione-S-transferases (GSTs), UDP-
glucuronoslytransferases (UGTs), and sulfotransferases (SULTs); and phase III 
transporters such as the multidrug resistance associated proteins-1 and -2 (MDR1 and 
MDR2) and the organic anion transporter polypeptide 2 (OATP2).  Furthermore, PXR 
has been termed the master regulator of CYP3A4 gene expression, which mediates the 
metabolism of over 50% of prescription drugs in humans.44, 45  In humans, PXR is 
expressed mainly in the liver and intestines.  PXR also regulates other pathways 
including bile acid detoxification and cholestasis, adrenal steroid homeostasis, lipid 
metabolism, inflammation and inflammatory bowel disease, and bone homeostasis.46  
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The complete extent of gene regulation by PXR is still being determined, as recent 
studies have implicated new genes previously not classified as PXR targets.49, 50            
The general structure of PXR is similar to that of other nuclear receptors and 
contains an N-terminal ligand-independent transcriptional factor (AF-1) domain followed 
by a highly conserved DNA binding domain (DBD), characterized by two C4-type zinc 
fingers.  A flexible hinge region connects the DBD to the ligand binding domain (LBD), 
which in addition to the ligand binding pocket (LBP) contains hetero- and homo-
dimerization motifs and the ligand-dependent transcriptional regulation docking site, 
known as activation factor 2 (AF-2).  PXR heterodimerizes with its obligate DNA 
binding partner, retinoid X receptor α (RXRα), and binds to a variety of xenobioitic 
recognition elements (direct repeats DR-3, DR-4, DR-5 and everted repeats ER-6 and 
ER-8), in the promoter regions of target genes.44, 45  Studies with human PXR indicate 
sublocalization in the nucleus even in the absence of activating ligand,50-52 however; 
localization may be species dependent, as studies in mice have shown that PXR is 
localized in the cytoplasm and translocates to the nucleus after receptor activation.51, 53   
In the absence of ligand, the AF-2 domain of PXR preferentially interacts with 
corepressors, specifically small heterodimer partner (SHP) and silencing mediator for 
retinoid and thyroid receptors (SMRT),50 which contain LXXX(L/I)XXX(L/I) or 
(L/V)XX(I/V)I motifs, where I is isoleucine, L is leucine, V is valine, and X is any amino 
acid.  The corepressor serves as a platform for the recruitment of additional 
transcriptional repressors, such as histone deacetylases.  Agonist binding in the ligand 
binding pocket of the receptor switches PXR to an active state by inducing a 
conformational change in the AF-2 domain that releases the corepressor.  Coactivators 
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that contain the LXXLL motif, such as members of the p160 family of transcriptional 
activators, which includes steroid receptor coactivator-1 (SRC-1) and glucocorticoid 
receptor interacting protein-1 (Grip-1), are recruited along with basal transcriptional 
machinery, ultimately leading to gene expression.  This two-state model for 
transcriptional activation is a common paradigm for ligand-dependent activation of 
nuclear receptors and is depicted in Figure 2.1.  However, the discovery of corepressors 
that interact with agonist-bound nuclear receptors may require refinement of this 
model.54, 55          
 The overall fold of the ligand binding domain of PXR is similar to other NRs and 
consists of a three-layer “α-helical sandwich” that encloses the large, spherical binding-
pocket of PXR (Figure 2.2).   Unique to PXR, the LBD contains an insert of 50-60 amino 
acid residues located between α1 and α3 that creates an extended, five-stranded anti-
parallel β-sheet adjacent to the LBP (other NR LBDs contain only 2 or 3-stranded β-
sheets) and creates a novel α2 fold along the underside of the LBP.  Residues 178-191 of 
the insert are disordered in PXR LBD crystal structures, implying structural mobility.  
Additionally, the binding pocket of PXR is much larger (on the order of 2 to 3 times) than 
other NRs and contains hydrophobic and hydrophilic residues that interact with bound 
ligands.  As in other NR-LBDs, the PXR LBD ends with a short helix (termed αAF or 
α12) that is critical to the AF-2 region and thus coregulator binding. 
 The observed promiscuity of PXR ligand binding is due to structural mobility in 
the LBD that allows the binding pocket to expand and contract.  Comparison of the 
crystal structures of apo-PXR-LBD1 with those of bound to rifampicin,56 to hyperforin,57 
to SR128131 and to the combination of SR12813 and SRC-1 coactivator peptide58 reveals 
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that three main regions become disordered to create the space necessary to accommodate 
large agonists.  These regions are the flexible loop formed from residues 229 to 235, a 
hydrophobic loop formed from residues 309 to 321 that folds into α6 in some structures, 
and residues 192 to 210 that form a pseudo-helix or fold into α2, a “bona fide helix”, 
depending on the bound agonist.  These structures reveal that the region comprising the 
α2 helix directly contacts bound ligands and changes its conformation to accommodate 
specific ligands.  Additionally, α2 is believed to act as “trapdoor” to the ligand binding 
pocket, dropping out of the way to provide a dynamic entry and exit way to the LBP of 
PXR.  The crystal structure of SR12813 ligand alone showed three distinct binding 
conformations within the LBP, suggesting that the LBD of PXR “breathes” to allow the 
ligand to find the optimal binding orientation, and binding of the SRC-1 coactivator locks 
the ligand into a single conformation, stabilizing the interaction.44  Interestingly, the 
crystal structure of the LBD of PXR bound to the endobioitic ligand 17β-estradiol (272 
Da) showed that 1000 Ǻ3 of the ligand binding pocket was unoccupied.59    
For many studies including in crystal structures, small α-helical peptides that 
contain the LXXLL or LXXX(L/I)XXX(L/I) motifs, termed NR boxes or interaction 
domains (ID), observed in coactivators and corepressors, respectively, are used instead of 
the corresponding full length proteins.  Transcriptional coregulators generally contain 
several interaction domains, and NRs exhibit preferential binding to a particular ID 
within the coregulator.60  The crystal structure of PXR bound to ID2 of SRC-1 reveals 
that the coactivator binding motif contains a two turn α-helix, which forms a charge 
clamp with the AF-2 region of PXR, connected to a second short, kinked helix that is 
perpendicular to the first.44  The corepressor motif contains a three turn α-helix that 
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interacts with the corepressor docking site, located in NRs on α helices 3 through 5.  The 
coregulator binding sites overlap each other, and ultimately the position of the αAF/α12 
helix determines whether the coactivator or corepressor binds to the LBD of the NR.55   
Crystal structure data have also revealed that PXR forms a novel homodimer at an 
interface created by the extended β-sheet observed in the LBD domain of PXR.58  The 
β1’ strands from each monomer associate in an antiparallel fashion, creating the 
homodimer interface, to form a 10-stranded intermolecular, β-sheet.  The association of 
the β1’ strands is stabilized by intermolecular hydrogen bonding between the main-
chains and through interlocking tryptophan and tyrosine residues (Trp223/Try225) that 
form an aromatic zipper at the dimer interface.  Further studies have shown that removal 
of the tryptophan zipper resulted in loss of homodimerization, but did not affect the 
ability of the receptor to bind to DNA, to heterodimerize with RXRα, or to bind to 
activating ligands, and did not alter the subcellular localization of the receptor.61  
However, the recruitment of transcriptional coactivators has been shown to be dependent 
on PXR’s ability to homodimerize,61 indicating that long-range motions “communicate” 
stabilizing effects from homodimerization to the AF-2 domain.62  Therefore, it has been 
proposed that the functional unit of PXR is a heterotetramer that is comprised of a PXR 
dimer bound to two separate RXRα units.61, 62  
As mentioned above, PXR is activated by a wide range of ligands ranging from 
natural products, such as the active ingredient of St. John’s wort, hyperforin, to 
prescription drugs, such as antibiotics (rifampicin) and anti-cancer drugs (paclitaxel), as 
well as endogenous compounds such as vitamin D and lithocholic acid, a by-product of 
cholesterol metabolism.  Table 2.1 gives a list of selected PXR activators and their 
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relative potency.  The inadvertent upregulation of metabolizing enzymes by PXR often 
leads to undesirable drug-drug interactions such as reduced efficacy of co-administered 
therapeutic drugs or the generation of toxic levels of drug metabolites.  The classical 
example of this type of interaction is the failure of estrogen-containing oral 
contraceptives due to their increased metabolism by PXR gene products when taken with 
other known PXR activators such as rifampicin or St. John’s wort.  To avoid these 
interactions, high throughput screening methods to detect possible PXR agonists have 
been developed using in vitro methods63, 64 and a commercialized kit is available.64  As 
the potency of PXR activation by agonists has been shown to be species specific, the 
development of in vivo screening methods in animal models may not be optimal unless 
“humanized” models are used.65, 66  Additionally, computational modeling methods have 
been developed to screen potential agonists based on structural similarity to known 
activators, through computational docking of ligands to the three dimensional structures 
generated from x-ray crystallography, NMR structures, or homology modeling of the 
protein, or through combination of both (reviewed in 67, 68).       
 
Table 2.1 Selected Agonists of PXR 
    
 
     
Compound Function 
Mol 
Wt.(Da) Kd EC50 Ref 
      
17β-Estradiol hormone 272  22 µM 59 
Paclitaxel anti-cancer drug 854  5 µM 69 
Rifampicin antibiotic 823  0.8 µM 70 
SR12813 cholesterol lowering drug 507 27 nM  71 
Hyperforin active ingredient in St. John's wort 537 41 nM  1 
Dexamethasone anti-inflammatory agent 392  10 µM 70 
Phenobarbitol barbiturate 232  370 µM 72 
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 Another method for preventing PXR mediated drug-drug interactions is through 
the therapeutic use of PXR antagonists.  Until recently, very few PXR antagonists had 
been identified, but the list is steadily growing, due in part to the discovery that 
antifungal azoles such as ketaconazole, which were first characterized as weak agonists 
of PXR, act as antagonists to ligand bound PXR.  Studies showed that these PXR 
antagonists allosterically inhibit the receptor by binding in the same hydrophobic groove 
to which the coactivator binds.73, 74  Computational modeling and docking studies of this 
interaction eventually lead to the discovery of novel antagonists through database 
searching of commercially available molecules and through computer-aided antagonist 
design methods.67, 68, 75-77  Table 2.2 presents a selected list of known PXR antagonists 
along with their corresponding half maximal inhibitory concentrations (IC50), which are a 
measure of the concentration of the antagonist necessary to achieve a 50% reduction in 
the signal that results from the activation of PXR in the presence of a known agonist.  
   
Table 2.2 Selected Antagonists of PXR 
   
 
    
Compound Function Mol Wt (Da) IC50 Ref 
     
Ecteinascidin  
(ET-743) anti-tumor drug 762 2 nM 69 
Ketaconazole anti-fungal 531 ~20 µM 73 
Fluconazole anti-fungal 306 ~20 µM 74 
Enilconazole fungicide 297 ~20 µM 74 
Leflunomide drug for rheumatoid arthritis 270 6.8 µM 75 
 
Despite the plethora of studies as to the nature of gene activation by PXR, there 
are still many questions concerning the mechanisms of recruitment of transcriptional 
coregulators and the overall role of agonist and antagonists in the modulation of protein 
production through binding to nuclear receptors.  To date, there have been very few 
30  
experimental studies that quantitatively measure the interaction of PXR with its 
transcriptional coregulators, agonists, and antagonists.  As such the goal to this study is to 
use total internal reflection fluorescence microscopy (TIRF) to measure the binding 
equilibrium of the LBD of PXR to a peptide analog of the steroid receptor coactivator-1 
(SRC-1) in the presence of rifampicin, a known ligand and classic transcriptional 
activator.  The rates will be used to quantitatively define the cyclic nature of the ligand 
dependent binding of coregulators to PXR.  As TIRF requires that the LBD of PXR be 
immobilized at the solid-solution interface, this chapter also briefly describes the 
development of immobilization techniques that preserve biological functioning of the 
immobilized species.   
 
2.2 Theory 
2.2.1 Equilibrium Binding of Coactivator Peptide in the Absence of Ligand 
To measure the equilibrium binding of the LBD of PXR using TIRF, the receptor 
is irreversibly immobilized at a solid-solution interface (see Methods) at which a laser is 
internally reflected.  Enough fluorescently-labeled coactivator is added such that the 
bound coregulator density is constant and the solution concentration is known.  The 
presumed reaction scheme is 
1CRA ⇔+  (1) 
RA
CK 11 =   (2) 
1CRRT +=   (3) 
where A is the solution concentration of fluorescently-labeled coregulator, R is the 
surface density of free receptor, C1 is the surface density of receptor complexed with 
31  
fluorescent coregulator, RT is the total surface density of deposited receptor, and K1 is the 
equilibrium binding constant for the association of free receptor, R, with fluorescently-
labeled coregulator, A.  The resultant evanescently excited fluorescence from the surface 
is  
1QCF =   (4) 
where Q is proportionality constant, and substituting for C1 and R using equations (2) and 
(3) gives 
TQRAK
AKF
1
1
1+
=  (5) 
 
which has the standard form for the binding of a monovalent ligand to an immobilized 
receptor.   
By measuring the evanescently excited fluorescence at increasing solution 
concentrations of A, a plot of F versus A is obtained (Figure 2.3a).  After background 
subtraction, the equilibrium constant K1 can then be extracted by fitting the curve to 
equation (5).  To measure the background signal, negative controls that lack the 
immobilized receptor are made, and the fluorescence intensity is recorded as function of 
solution concentration of the fluorescently labeled coregulator, as the background 
solution fluorescence increases linearly as a function of A (F=QAd, where d is the depth 
of the evanescent wave).  The negative controls also account for contributions to the 
signal from nonspecific background.  For simplicity, contributions from background will 
be ignored in the discussion of the theory.    
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2.2.2 Effect of Nonfluorescent Ligands    
Addition of non-fluorescent ligands of PXR to the solution containing 
fluorescently labeled coregulators in the presence of the immobilized LBD of PXR, 
results in a multiple reaction system.  The presumed reaction scheme (depicted in Figure 
2.4) is 
1CRA ⇔+   (1) 
2CRL ⇔+   (6) 
31 CCL ⇔+   (7) 
32 CCA ⇔+   (8) 
where L is the solution concentration of nonfluorescent ligand, C2 is the surface density 
of receptor complexed with nonfluorescent ligand, and C3 is the surface density of 
receptor complexed with ligand and fluorescent coregulator.  This generates four 
equilibrium association constants  
RA
CK 11 =    (2) 
RL
CK 22 =   (9) 
LC
CK
1
3
3 =   (10) 
AC
CK
2
3
4 =   (11) 
where K2 is the association constant for ligand and receptor, K3 is the association 
constant for receptor-coregulator complex and ligand, K4 is the association constant for 
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receptor-ligand complex and coregulator and all K values have units of (solution 
concentration)-1.  The total concentration of receptors on the surface is defined by  
321 CCCRRT +++=  (12) 
and the resulting fluorescence from surface bound evanescently excited molecules is 
)( 31 CCQF +=  (13) 
with the assumption that Q is equivalent for C1 and C3. 
As the scheme outlined above is cyclic, the equilibrium constants are related.  By 
using equations 10-13 and by simplifying we find that    
4231 KKKK =  (14) 
Therefore, by substituting for C1 and C3, equation 15 for the measured surface-associated 
fluorescence, after correction for background and contributions from solution, can be 
written as  
 
=
+++
+
= TQRLAKKLKAK
ALKKKLAF
4221
421
1
)(),(    
TQRLAKKLKAK
ALKK
3121
31
1
)1(
+++
+
 (15) 
where the second equation follows from the relationship defined in equation 14.  Note 
that at the limits of A=0 and A=∞ 
 
0),0( =LF      (16) 
TT QRQRLAKKAK
ALKKLF =
+
+
→∞
311
31 )1(),(  (17) 
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Thus, when  there are no fluorescent coregulators present, the measured fluorescence is 
zero, and, when the concentration of fluorescent coregulators is very high, the surface-
immobilized receptors are saturated with coregulator and the signal is proportional to the 
total surface concentration of receptor.  Also, applying the same limits to the ligand 
concentration results in  
 
TQRAK
AKAF
1
1
1
)0,(
+
=     (18) 
TT QRAK
AKQR
LAKKLK
LAKKAF
4
4
422
42
1
),(
+
=
+
→∞   (19) 
Therefore, when the concentration of ligand is zero, the equation for the surface 
fluorescence is equivalent to equation 5 and, of the four, only the association constant K1 
contributes to the observed signal. When saturating concentrations of ligand are present 
(L=∞), the resulting fluorescence is dependent on the association of C2 with A, which is 
described by K4.  Additionally, equation 17 can be written as  
 
=
+
+
+
+
+
= TQR
A
LK
LKK
A
LK
LKK
LAF
)
1
1(1
)
1
1(
),(
2
3
1
2
3
1
 
T
a
a QR
AK
AK
+1
   (20) 
where Ka is an “apparent” K, depends on L, and is given by 
 
)
1
1(
2
3
1 LK
LKKKa +
+
=     (21) 
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At the limits,  
10][ KK La ==      (22) 
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2
3 )(][ KK
K
KK La ==∞=    (23) 
which is in agreement with equations 16 and 17.  Additionally, equation 21 can be 
rewritten using equation 14 as 
LK
LKKKKa
2
421
1+
+
=     (24) 
Using TIRF, the surface fluorescence as a function of A is measured for 
increasing, constant values of L (to beyond a saturating concentration).  In other words, 
multiple binding curves as a function of A are collected at different, constant 
concentrations of L.  After background correction, each curve is fit to  
 
T
a
a QR
AK
AKAF
+
=
1
)(     (25) 
For each binding curve, best-fits of the data should give equivalent values of QRT but 
values of Ka that depend on L (Figure 2.3b).  The Ka values are then plotted as function 
of L, and fitted to equation 21, where K2 and K3 are free parameters and K1 is determined 
from the curve taken when the concentration of ligand is zero.  Using the relationship 
defined in equation 16, K4 can then be determined.  When the coregulator is a coactivator 
that acts by a mechanism in which the ligand increases the association constant for the 
coactivator and receptor such that K3 > K2, the Ka vs L plot appears as shown in Figure 
2.5, where Ka ranges from K1 to K4>K1.  If the coregulator is a corepressor in that K3 < 
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K2, the data would be similar, except that the plot would decrease from a maximum at L 
= 0 (K1) to a minimum at at L = ∞ (K4). 
 
2.3 Materials and Methods 
2.3.1 Materials 
 All chemicals were purchased from Fisher Scientific (Fairlawn, NJ) unless 
otherwise specified.  Deionized (DI) water was generated using a NANOpure® II water 
purification system (Barnstead International, Dubuque, IA).  All lipids were purchased 
from Avanti Polar Lipids (Alabaster, Alabama).  Purified biotin protein ligase (BirA), 
Biomix A, and Biomix B, were purchased from Avidity (Aurora, Colorado). 
2.3.2 Slide Cleaning 
Fused-silica slides (1” x 1” x 1 mm, cut in house from 3” x 1” x 1 mm slides, 
Quartz Scientific Inc, Fairport Harbour, OH) and glass microscope slides (Gold Seal® 
Products, Portsmouth, NH) were cleaned in detergent.  Cleaning was carried out by 
boiling slides in a 10% solution of 7X -ICN detergent (MP BioMedicals, Solon, OH), by 
bath sonicating for 30 minutes and by thoroughly rinsing with DI water.  The slides were 
then sonicated in DI water for an additional 30 minutes, were rinsed again, and were 
dried at 160oC.   For test tubes and vials used for lipid preparation, base cleaning was 
carried out by soaking slides in a solution containing 120 g of potassium hydroxide 
dissolved in 120 mL of DI water and diluted to 1 L with 95% ethanol (AAPER Alcohol, 
Shelbyville, KY) for 10 minutes, washing with 95% ethanol, and then rinsing with DI 
water until the pH of the solution returned to neutral. 
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2.3.3 Immobilizing Proteins Using His6 Tags 
2.3.3.i EGFP-His6 Expression and Purification 
Glycerol stocks of Escherichia coli (E. Coli) cells transformed with a plasmid 
containing enhanced green fluorescent protein (EGFP) with a C-terminal His6 tag under a 
T7 promoter (a gift from Dr. Dorothy Erie’s lab, UNC chemistry) were used to express 
protein using standard procedures.  Briefly, a starter culture of liquid Luria Broth with 
100 µg/mL of ampicillin (LBAMP) was inoculated with a single colony and grown 
overnight.  This starter culture was used to inoculate (1:100 dilution) 2 L of fresh LBAMP.   
Once the optical density at 600 nm was between 0.5 to 0.7, the culture was induced with 
a final concentration of 100 µM isopropyl-β-D-thiogalactopyranoside (IPTG) (99% Pure, 
Dioxane-free; Promega Corp, Madison, WI) and was grown for 4 hours.  All cultures 
were grown at 37˚C with constant shaking at 225 rpm.  Cells were harvested by 
centrifugation (Sorvall RC-3B, Sorvall Instruments, Newtown, CT) at 1600 g for 20 min 
at 4˚C.  The pellet was frozen at -80°C prior to protein purification.   
The cell pellet was resuspended in lysis buffer (50 mM sodium phosphate pH 7.8,  
300 mM NaCl, 5 mM imidazole, and 1 mM phenylmethanesulphonylfluoride (PMSF), 
before adding lysozyme (1 mg/mL working concentration) and reacting for 30 min at 4°C 
with gentle agitation to lyse the cells.  The cell solution was then tip sonicated using 10 
second pulses for 1 minute, and cell debris were removed by centrifugation (Sorvall RC-
3B) at 27000 g.  The supernatant was 0.4 µm filtered, before running down a 
Sepahrose®4-B (Sigma-Aldrich, St. Louis, MO) guard column connected to a nickel 
nitrilotriacetic acid column (Ni-NTA) (Qiagen, Valencia, CA).  The column was washed 
with buffer containing 50 mM sodium phosphate pH=8.0, 300 mM sodium chloride, and 
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20 mM imidazole until the absorbance at 280 nm was less than 0.01, and 1 mL fractions 
were eluted with buffer containing 50 mM sodium phosphate pH=8.0, 300 mM sodium 
chloride, and 250 mM imidazole.  The fractions containing EGFP were then pooled and 
dialyzed into PBS (phosphate buffered saline; 0.05 M sodium phosphate pH=7.4, 0.15 M 
sodium chloride, 0.01% sodium azide) overnight at 4°C.  The concentration of the protein 
was determined spectrophotometrically using the molar extinction coefficient (ε) of 5.5 x 
104 M-1cm-1 at 488 nm.   
2.3.3.ii Vesicle Fusion and Sample Preparation 
For imaging studies, small unilamellar vesicles (SUVs) consisting of  5% 1,2-
Dioleoyl-sn-Glycero-3-[N-(5-amino-1-carboxylpentyl)iminodiacetic acid)succinyl] 
(Nickel Salt) (Ni-DOGS-NTA); 93% 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine 
(DPPC); 2% 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) (Ammonium Salt) (NBD-DPPE) were prepared by vesicle fusion.  
For control measurements, SUVS consisting of 98% (DPPC); 2% (NBD-DPPE) were 
also prepared.  Lipids were mixed in chloroform, were dried under vacuum overnight, 
and were suspended in 3 mL of DI water such that the total concentration of lipids was 2 
mM.  The suspended mixture was then tip sonicated (Fisher Sonic Dismembrator, Model 
300) for 15 minutes at 40-80% power in an ice bath to form SUVs.  For TIRF 
measurements,  5 mol% Ni-DOGS-NTA, 95 mol% DPPC or 100 mol% 1-Palmitoyl-2-
Oleoyl-Glycero-3-Phosphocholine (POPC) were made using the methods described 
above.   
Immediately prior to use, fused silica substrates and glass slides were argon ion  
plasma cleaned for 10 minutes (PDC-3XG, Harrick Scientific, Ossining, NY), and the 
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vesicle suspension was clarified by air ultracentrifugation at 130,000 g for 30 min 
(Beckman Airfuge; Beckman-Coulter, Fullerton, CA).  Planar substrate supports were 
formed by attaching fused-silica substrates (1 in x 1 in x 1 mm) to glass microscope slide 
(1 in x 3 in 1 mm) using double-sided tape (3M Corp., Part No. 021200-64988) to form 
slide “sandwiches”.  To the internal volume of the sandwich, 75 µL of SUVs were 
applied and incubated at room temperature for 1 hour before washing with 3 mL of PBS 
or PXR buffer (20 mM Tris pH 7.8, 250 mM sodium chloride, 5 mM dithiothreitol 
(DTT), 5% glyercol).   
2.3.3.iii Equilibrium Binding of EGFP to Ni- DOGS-NTA Membranes 
To study the equilibrium binding of EGFP to Ni-NTA-DOGS membranes using 
TIRF, slide sandwiches with lipid bilayers consisting of 5 mol% Ni- DOGS-NTA, 95 mol 
% DDPC or 100 mol% POPC were made as described above.  To each slide, 200 µL of 
0.5 to 10 µM EGFP in PBS were added, and evanescently-excited fluorescence intensity 
was measured for nine spots on each slide using the TIRF system described below.  Three 
completed data sets were collected and averaged to obtain the equilibrium binding 
constant (Kd).  Sigma Plot® (Systat Software Inc., San Jose, CA) was used for data 
analysis and curve fitting. 
2.3.4 AviTag-His6-LBD-PXR  
2.3.4.i Plasmids  
 The LBD of human PXR, amino acids 130-434, containing a N-terminal His6 tag 
was cloned into a commercially available vector containing an N-terminal AviTag insert 
(pAN4 vector; Avidity), using standard cloning techniques (work completed by Yuan 
Cheng under direction of Dr. Matthew Redinbo).  The successful insertion of the 
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sequence was confirmed by DNA sequencing using commercially available primers 
(FASP and RSAP, Avidity).  The AviTag-His6-LBD-PXR forthwith will be referred to as 
b-PXR.  A plasmid coding for an 88 amino acid fragment of SRC-1 (residues 623-710) 
was provided by Dr. Matthew Redinbo.1   
2.3.4.ii Expression and Purification  
 b-PXR was co-coexpressed in E. Coli cells with the SRC-1 plasmid in either the 
BL21 (DE3) or BL21 (AI) strain (Invitrogen Corp, Carlsbad, CA).  For expression in 
BL21 (DE3) cells, an overnight culture containing 100 µg/mL of ampicillin and 35 µg/ml 
chloramphenicol in LB (LBAMP-CHLOR) was grown from a single colony and a 1:100 
dilution of this cultrure was used to start a 1.5 L culture of TB (24 g/L yeast extract, 12 
g/L tryptone, 17 mM potassium phosphate monobasic, 72 mM potassium phosphate 
dibasic, 0.4% glycerol) at the same concentration of antibiotic (TBAMP-CHLOR) or 1.5 L 
culture of LBAMP-CHLOR.  The cells were grown to an optical density at 600 nm (OD600) of 
approximately 0.6 at 37°C with shaking (225 rpm), and then induced with 50 µM to 1 
mM of IPTG and allowed to grow at 37°C for 4 hours or overnight at 18°C.  
Alternatively, a 1.5 L culture of TBAMP-CHLOR was started as described above, IPTG was 
added, and the culture was allowed to grow overnight at 22°C.  For expression in BL21 
(AI) cells, a 1.5 L culture of TBAMP-CHLOR was started as described, grown until an OD600 
of approximately 1.0 was reached, induced with 1 mM IPTG and 0.1% L-arabinose (98% 
pure, Sigma-Adrich), and allowed to grow at 37°C for 4 hours.  For all cell preps, cells 
were collected by centrifugation (3000 g, 20 minutes), and the cell pellet was frozen at -
80°C until protein purification. 
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 For all cultures, the cell pellet was resuspended in Ni-A wash buffer (20 mM Tris, 
pH 7.8, 250 mM sodium chloride, 20 mM imidazole, 5% glycerol) with 2 mM PMSF,  50 
µg/mL DNase, 5 µg/mL aprotinin and 5 µg/mL leupeptin and was tip sonicated using 5 
second pulses with 10 second off cycles for 3 minutes.  The mixture was then centrifuged 
at 27000 g for 45 minutes to pellet cell debris, and the supernatant was collected and 0.45 
µm filtered (Millex-HV syringe filters; Millipore Corp., Billerica, MA) before loading 
onto a Ni-NTA column.  The column was then washed with 400 mL of Ni-A buffer, and 
was eluted using Ni-E buffer (20 mM Tris, pH 7.8, 250 mM sodium chloride, 300 mM 
imidazole, 5% glycerol).  The fractions containing protein were pooled and dialyzed 
overnight into biotinylation buffer (20 mM Tris pH 7.8, 250 mM NaCl, 10 mM 
imidazole).  All steps were performed at 4°C.  Protein purity was ascertained using SDS-
PAGE with Coomassie blue staining. 
Protein expression was verified using western blotting with anti-His3-horseradish 
peroxidase (HRP) antibodies (His-probe (H-3) HRP; Santa Cruz Biotechnology, Inc, 
Santa Cruz, CA) by pelleting 1 mL of cell culture.  After discarding the supernatant, the 
cell pellet was resuspended in 0.25 mL of Ni-A buffer and put through a freeze-thaw 
cycle three times to lyse cells.  The samples were then centrifuged to remove cell debris, 
and an aliquot of the supernatant was diluted 1:1 with 2x SDS-Loading Buffer (250 mM 
Tris-base pH=6.9, 40% (v/v) glycerol, 9.25% (w/v) SDS, 0.1% bromophenol blue, 10% 
(v/v) β-mercaptoethanol).  Alternatively, purified protein at a concentration of 1 µM was 
diluted 1:1 with 2x SDS-Loading Buffer, and all samples were loaded onto a 10% Tris-
HCl ready gel (BioRad Laboratories, Hercules, CA) with 6xHis protein ladder (Qiagen).  
The gel was run at 120 V for 20 minutes, then at 180 V until complete, before 
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transferring to a PVDF membrane in 20 mM Tris-HCl, 20 mM glycine buffer at 350 mA 
for 60 minutes at 4°C.  The membrane was blocked in 10 mM Tris pH=7.5, 150 mM 
sodium chloride, 5% (w/v) non-fat dried milk, and 0.05% Tween-20 buffer (TBST) for 
45 minutes, was incubated with 1:1000 dilution of anti-His3 antibody in TBST for 1 hour, 
was washed three times for 15 minutes with TBST, and was thoroughly washed with DI 
water to remove the milk.  The blocking, incubation, and washing steps were all 
completed at room temperature.  In the dark room, the blot was incubated with ECL 
detection chemical (Pierce Biotechnology, Rockford, IL) for 2 minutes and was exposed 
to Amersham Hyperfilm ECL photosensitive film (GE Healthcare, Piscataway, NJ) for 8-
16 seconds.  The film was developed using standard procedures. 
2.3.4.iii Biotinylation of b-PXR 
 Purified b-PXR in biotinylation buffer was concentrated to 0.2 mg/mL using 
Amicon Ultra MWCO 10,000 (Millipore).  Protein concentration was determined using 
Bio-Rad Protein Assay and BSA standards according to manufacturer’s protocols.  The 
protein was biotinylated according to manufacturer’s instructions (Avidity product 
inserts).  Briefly, the sample was diluted 8:1:1 b-PXR in biotinylation buffer, Biomix A, 
and Biomix B, and 2.5 µg of BirA were added for every 10 nmoles of b-PXR.  The 
solution was allowed to react overnight at 4°C.  To remove excess biotin, the sample was 
purified using Ni-NTA chromatography as described previously, and eluted B-PXR 
(biotinylated b-PXR termed B-PXR to distinguish addition of the biotin label) fractions 
were dialyzed into PXR buffer overnight at 4°C.  After concentration, the protein samples 
were frozen in liquid nitrogen and stored at -80°C until use. 
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Biotinylation was confirmed using western blotting with anti-biotin-HRP 
antibodies (Santa Cruz Biotechnology).  Briefly, samples containing B-PXR were diluted 
1:1 with 2x SDS-Loading Buffer and run on a 10% Tris-HCl gel, as described previously, 
along with biotinylated protein ladder (Sigma-Aldrich).  The gel was transferred to 
nitrocellulose membrane in 20 mM Tris-HCl, 20 mM glycine, 20% methanol buffer at 
350 mA for 60 minutes at 4°C.  The membrane was blocked in 5% bovine serum albumin 
(BSA) in b-TBS (20 mM Tris pH=7.5, 500 mM sodium chloride) overnight at 4°C.  The 
blot was incubated with 1:2000 dilution of anti-biotin-HRP antibody in 3% BSA in b-
TBST (b-TBS with 0.05% Tween-20) for 1 hour, was washed twice for 5 minutes with b-
TBST, followed by two five-minute washes in TBS.  The incubation and washing steps 
were completed at room temperature.  In the dark room, the blot was developed as 
described above. 
 2.3.5 Fluorescent Labeling of SRC-1 peptide 
 A twenty five amino acid peptide of ID2 of SRC-1 peptide was synthesized by the 
UNC Microprotein Sequencing & Peptide Synthesis Facility.  The peptide sequence is 
676-CPSSWSSLTERHKILHRLLQEGSPS-700 
where residue 680 has been mutated from the original sequence (H to W).58  The average 
molecular weight is 2849.21 and the monoisotrophic molecular weight is 2847.44.  The 
peptide was fluorescently labeled using either Alexa Fluor® 488 C5 maleimide or 
fluorescein-5-maleimide (Molecular Probes, Carlsbad, CA) by incubating the peptide 
with a 2 to 3 mole excess of fluorophore and with a 10 mole excess of tris(2-
carboxyethyl)phosphine (TCEP) in 30 mM ammonium bicarbonate, 25 mM NaCl 
pH=7.5 overnight at 4°C.  The reactions were stopped by adding an excess of 2-
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mercaptoethanol, before purification to remove excess free dye.  For labeling with Alexa 
Fluor® 488, the pH of the sample was adjusted to 5.0 using 0.1 M acetic acid, and the 
mixture was run down a Q SepharoseTM  ion exchange column (GE Healthcare) 
equilibrated in 30 mM ammonium acetate pH=5.0.  For fluorescein labeling, the sample 
was run down the Q SepharoseTM ion exchange column equilibrated in 30 mM 
ammonium bicarbonate pH=8.0.  For both systems, the labeled peptide eluted in 
equilibration buffer, and peptide fractions were collected and lyophilized.  The 
lyophilized samples were reconstituted in water, and purified by high performance liquid 
chromatography (HPLC), using a 0 to 40% gradient of solvent B (95% acetonitrile, 5% 
water 0.1% trifluoroacetic acid) in solvent A (95% water, 5% acetonitrile, 0.1% 
trifluoroacetic acid), to remove salt.    All samples were run on a Atlantis C18 Prep T3 
column (10 x 100 mm) using a Waters HPLC with Delta 600 pump and controller 
(Waters Corp, Milford, MA).  HPLC fractions were collected and lyophilized, and the 
purified peptide was stored at -20°C.  Peptide labeling and purity were confirmed using 
mass spectrometry.         
2.3.6 Surface Immobilization of Receptors Using NeutrAvidin (Control Experiments) 
For control experiments, NeutrAvidin (Pierce Biotechnology) (NAv) and B-PXR 
were labeled with fluorescein isothiocyanate (FITC) and fluorescein-5-maleimide 
respectively, using standard procedures.  NeutrAvidin was weighed out and dissolved in 
0.1 M sodium bicarbonate pH=9.0 at a concentration 0.5 mg/mL and reacted with a 20 
mole excess of FITC for 1 hour at room temperature.  B-PXR in PXR buffer lacking DTT 
was reacted with 20 mole excess of fluorescein-5-maleimide in the presence of 10 mol 
excess of TCEP for 2 hours at 4°C.  For both proteins, the free dye was separated from 
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the protein by running the mixture down a G-25 Sephadex® (Sigma-Aldrich) column that 
was equilibrated in PXR buffer.  Eluted fractions were collected, pooled, and 
concentrated using Amicon YM-10 centrifugal concentrators.  For B-PXR, the 
concentration of the protein was determined using BioRad Protein Assay and BSA 
standards, and the labeling ratio was determined using the concentration of protein and 
the concentration of fluorophore, which was determined spectrophometrically using 
ελ=492=83,000 M-1cm-1 for fluorescein-5-maleimide.  For NAv, the concentration and 
labeling ratio were determined spectrophotometrically using ελ=280=1.66 for NAv at 
concentration of 1 mg/mL (Pierce Biotechnology, product insert), CF280=0.3 and 
ελ=494=68,000 M-1cm-1 for fluorescein-5-maleimide, where CF is correction factor 
(ελ=280/ελ=494). 
For control measurements, 50 µL of a solution containing 0.5 mg/mL of 
fluorescein labeled NAv (F-NAv), 0.1 mg/mL of ovalbumin (Ova) (98% pure; Sigma-
Aldrich) or of a solution containing 0.5 mg/mL NAv, 0.1 mg/mL Ova in DI water were 
pipetted into a fused-silica/slide “sandwich” and allowed to non-specifically adsorb for 1 
hour at room temperature, before being rinsed with 2 mL of PXR buffer.  To the non-
fluorescent slide, 200 µL of a 0.1 mg/mL solution of fluorescein-5-maleimide labeled B-
PXR (FM-B-PXR) were added, and the slide was incubated at room temperature for 5 
minutes, before rinsing with 1 mL of PXR buffer.    After 30 minute incubation intervals 
at room temperature, the slides were washed with an additional 1 mL of PXR Buffer.  At 
each time interval (t=0 to 60 minutes), using TIRF the average evanescently-excited 
fluorescence intensity over 10 seconds was measured for 4 different spots on each slide, 
and the four values were averaged for comparison. 
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2.3.7 Equilibrium Binding of SRC-1 to Immobilized B-PXR 
 For TIRF measurements, samples were created by pipetting 50 µL of a solution 
consisting of 0.5 mg/mL NAv, 0.1 mg/mL in water or PXR buffer, which had been 
clarified using ultracentrifugation immediately prior to use (see lipid procedure), into a 
slide sandwich and incubating for 1 hour at room temperature.  The slide was then 
washed with 2 mL of PXR buffer.  For positive controls, immediately prior to use 200 µL 
of a 0.1 mg/mL solution of B-PXR, which was kept on ice until use, was injected into the 
sandwich, incubated for 5 minutes, and washed with 1 mL of PXR buffer.  Then, 150 µL 
of PXR buffer containing rifampicin, at concentrations ranging from 10 nM to 1 µM, and 
the fluorescently labeled SRC-1 peptide (typically with a labeling ratio of less than 10%), 
at concentrations ranging from 0.5 µM to 200 µM, were pippetted into sandwich.  The 
sample was mounted, excited using TIRF, and the fluorescence intensity was recorded as 
an average over 10 seconds for nine spots on each sample.  For negative controls, the 
process was repeated except 150 µL of buffer were added to the slide in place of B-PXR.  
Sigma Plot® was used for data analysis and curve fitting.     
2.3.8 Apparatus for TIRF and Epifluorescence  
Through-prism total internal reflection experiments were carried out on an 
instrument consisting of an inverted microscope (Zeiss Axiovert 35, Thornwood, NY), an 
argon ion-laser (Innova 90-3; Coherent, Palo Alto, CA), and a single-photon counting 
photomultiplier (RCA C31034A, Lancaster, PA).  The instrument was controlled with an 
in-house LabVIEW program and DAQ board (PCI-MIO-16XE-50, Texas Instruments, 
Austin, TX), and the average fluorescence intensity was collected using a PC-based 
correlator board (model 5000/E, ALV).   All samples were excited using the 488 nm line, 
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and the evanescently generated fluorescence was collected using a 40x 0.55 NA LWD 
objective (Nikon Instruments Inc., Nelville, NY).  All experiments were conducted at 
room temperature.     
For imaging, the same instrument was used in epifluorescence mode.  The 
collected light was directed to a charge-coupled device (CCD) (Photometrics CH250) 
imaging detector connected to a PC with Photometrics PMIS Image 200 Processing 
Software (Tucson, AZ).  All 8-bit digitalized images were taken using an excitation 
wavelength of 488.0 nm, 40x water 0.75 NA objective, and an appropriate long-pass 
filter for fluorescence detection.  
2.4 Results  
 
2.4.1 Immobilizing Proteins at Surfaces using His6 Tags 
 
 In this experiment, the ability of nickel chelating lipids to coordinate to the 6x 
histidine tag of proteins was examined using a test system consisting of planar, lipid 
bilayers containing 5 mol% Ni-DOGS-NTA and enhanced green fluorescent protein 
(EGFP) with a C-terminal His6 tag.  To obtain equilibrium binding constants, the 
evanescently excited fluorescence generated by the association of EGFP in solution with 
Ni-DOGS-NTA lipid bilayers on a fused-silica surface was measured as a function of the 
solution concentration of EGFP using TIRF (Figure 2.6).  Negative controls, in which 
lipid bilayers consisting of 100 mol % POPC were used in place of Ni-DOGS-NTA 
membranes, were used to account for background fluorescence signal generated from 
EGFP that was diffusing within the evanescent wave but was not bound to the surface.  
After background subtraction, the curves were fitted to 
xK
xBF
d +
=
max
  (26) 
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where F is the measured fluorescence for a given EGFP solution concentration, Bmax is 
the fluorescence at saturation, x is the concentration of EGFP in solution, and Kd is the 
equilibrium dissociation constant.  From three complete sets of data, an average Kd of 
4.43 ± 0.62 µM was obtained, which is consistent with other previously reported values 
for the interaction of histidine tags with metal chelating lipids.78, 79  This weak binding 
constant suggests that reversible association between histidine-tagged proteins to lipid 
bilayers occurs, which is undesirable in these TIRF experiments.  As such, this method 
for immobilizing proteins at the solid-solution interface is not feasible for these TIRF 
experiments. 
2.4.2 Specifically Biotinylating the LBD of PXR  
 
  To biotinylate PXR at a single site on the protein surface, a specific recognition 
sequence called an AviTag was added to the N-terminal of the LBD of PXR, using a 
commercial DNA vector and standard cloning techniques.  The tag was added to the N-
terminal to preserve the structural integrity of the C-terminal LBP and AF2 domains.  
Biotin protein ligase or BirA, a naturally occurring E. Coli protein, recognizes the 
AviTag sequence and through an ATP dependent reaction adds a biotin to the terminal 
amine in the side chain of a lysine residue in the tag.  The cloning was verified using 
DNA sequencing, but attempts to co-express the AviTag/PXR plasmid with the SRC-1 
plasmid in BL21 (DE3) E. Coli cells resulted in no expression of b-PXR under all 
conditions tested.  As the commercial AviTag vector is under a trc promoter, which is a 
modified lac promoter, and the SRC-1 promoter is under a T7 promoter, the SRC-1 
plasmid was expressed to the exclusion of the AviTag/PXR plasmid in BL21 (DE3) cells.  
Co-expressing the plasmids in BL21 (AI) E. Coli cells resulted in expression of both 
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vectors, but with low protein yields of b-PXR (approximately 0.5 milligrams of b-PXR 
per liter of culture).  However, a sufficient amount of purified protein was obtained to 
conduct TIRF experiments.  To increase protein yield, molecular cloning is currently 
being performed to place the AviTag-PXR sequence in a plasmid that operates under a 
T7 promoter.   
Purified b-PXR was biotinylated in vitro using commercially purchased biotin 
protein ligase and reaction buffers.  As BirA is inhibited by sodium chloride, the reaction 
was allowed to proceed overnight to ensure maximum labeling efficiency.  The biotin 
labeling was verified by western blotting with anti-biotin antibodies.  Biotinylated protein 
ladder served a dual purpose, acting as a molecular weight marker and as a positive 
control, and b-PXR samples before addition of BirA served as a negative control.  As the 
molecular weight of BirA is similar to that of b-PXR, samples containing working 
concentrations of BirA and the supplied reaction buffers but without b-PXR were also 
run to exclude the possibility that the observed bands were generated from BirA.  Figure 
2.7 shows an example of a western blot of biotinylated PXR (B-PXR).        
2.4.3 Immobilizing Proteins at Surfaces Using Biotin-Avidin Interactions 
 A promising method for immobilizing proteins at the solid-solution interface for 
TIRF experiments is to use systems that take advantage of the strong binding of biotin by 
avidin (Ka on the order of 1015 M).  As such, NeutrAvidin (NAv), a modified form of 
avidin, was non-specifically adsorbed onto fused-silica surfaces in the presence of 
ovalbumin and was used to bind biotinylated biomolecules in solution, thereby 
irreversibly immobilizing them at the solid-solution interface.  To determine whether the 
non-specific adsorption of NAv to glass surfaces is irreversible, fluorescently labeled 
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NAv was immobilized onto fused-silica surfaces in the presence of ovalbumin.  The 
sample was then excited using TIRF, and the evanescently generated fluorescence was 
recorded for several spots on the sample and averaged.  After 30 minute time intervals, 
the slide was washed with buffer, and the average fluorescence intensity was measured 
again.  This experiment was repeated using NAv slides (non-fluorescent) that were 
incubated with fluorescently labeled B-PXR to determine whether biotin-labeled 
molecules are irreversibly immobilized on surfaces coated with NAv.   As the average 
evanescently excited fluorescence for both systems declined less than 5% over the 
observed time period (data not shown), it was concluded that NAv non-specifically 
adsorbs to glass surfaces in an irreversible fashion, and that, over the course of a typical 
TIRF experiment, the binding of biotinylated biomolecules by surface immobilized NAv 
is also irreversible.  Therefore, this system is a feasible method for immobilizing 
biological molecules at surfaces for TIRF experiments.   
2.4.4 Equilibrium Binding of B-PXR to SRC-1 Peptide 
 The equilibrium constants for immobilized B-PXR binding to Alexa®Fluor 488 
(A488) labeled SRC-1 peptide were determined for increasing concentrations of 
rifampicin using TIRF.  For a given, fixed concentration of rifampicin, the evanescently 
excited fluorescence was measured as a function of the solution concentration of A488-
SRC-1, and three complete sets of data were collected for each concentration of 
rifampicin.  After background subtraction, the three sets of data were normalized to each 
other using fluorescence intensities obtained at a single, overlapping concentration of 
A488-SRC-1, thus accounting for sample to sample variation in fluorescence intensity.  
The normalized data were plotted as a single curve and fit to   
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d
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where Bm is equal to QRT, A is the solution concentration of A488-SRC-1, and Kd is the 
inverse of Ka (see equation 21). The fitted curves are shown in Figure 2.8.  The 
equilibrium dissociation constants obtained for SRC-1 binding to immobilized B-PXR as 
a function of rifampicin concentration are listed in Table 2.3.  As expected, the 
equilibrium dissociation constant decreases with increasing solution concentration of 
rifampicin, indicating that the presence of ligand increases the affinity of B-PXR for the 
coactivator.       
Table 2.3 Kd for B-PXR Binding to SRC-1 
      
Rifampicin 
(µM) Kd (µM)   Error (µM)  
      
0  23.47  ± 4.78  
0.010  16.99  ± 3.31  
0.030  6.68  ± 2.42  
0.100  3.12  ± 0.64  
1.000  2.68  ± 0.99  
  
To determine the equilibrium association constants defined in equations 9-10, the 
Kd values in Table 2.3 were converted to their corresponding Ka values (Ka=1/Kd).  The 
values were then plotted as a function of the solution concentration of rifampicin (L) and 
fit to equation 24, with K2 and K4 as free parameters and setting K1 equal to the Kd 
obtained in the absence of rifampicin.  The fitted plot is shown in Figure 2.9 and has the 
predicted shape for coactivator binding to the LBD of PXR in the presence of ligand.  
Using the relationship defined in equation 14, K3 was then determined, and the calculated 
equilibrium association constants are shown in Table 2.4.  For all values, the reported 
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error corresponds to the standard error generated by curve fitting in Sigma Plot or is 
determined using standard equations for the propagation of error.   
 
Table 2.4  Calculated K's for B-PXR Binding to SRC-1 
      
Constant Ka  Error (±) Kd Error (±)  
      
     K1* 42.6 nM-1 8.7 nM-1 23.5 µM 4.8 µM  
     K2** 17.5 µM-1 7 µM-1 56.9 nM 22.5 nM  
     K3** 168 µM-1 77 µM-1 5.92 nM 2.71 nM  
     K4# 0.45 µM-1 0.043 µM-1 2.44 µM 0.25 µM  
           
      
*Measured using TIRF  
** Free parameters determined by fitting to Ka vs L plot  
# Determined using Equation 14 and K1, K2, and K3 values  
 
As it was discovered that one of the reagents in the sample buffer, DTT, activates 
PXR by forming a covalent bond to a cysteine (Cys284) in the ligand binding pocket,59 
the calculated equilibrium constants are most likely not completely accurate for the PXR, 
SRC-1, rifampicin system.  Subsequently, in experiments conducted using buffers made 
with newly purchased DTT, the ligand binding dependence of PXR to SRC-1 was 
diminished, and the receptor was believed to be in a permanently active state, as a Kd of 
~6 µM was obtained for SRC-1 binding to PXR in the absence of rifampicin (data not 
shown).  As such, experiments are currently being repeated with TCEP rather than DTT 
to determine accurate equilibrium binding constants.  However, the data shown in Figure 
2.8 strongly suggest that a ligand-dependent increase in the affinity of PXR for 
coactivator is observed.  Whether the exact values for the equilibrium constants listed in 
Table 2.4 will remain the same is yet to be determined.       
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2.5 Discussion 
 As TIRF is a surface specific technique, studying the dynamics of biochemical 
interactions that typically occur in solution requires the immobilization of one of the 
components at the solid-solution interface in a manner that does not disrupt the biological 
functioning of the system.  In this chapter, two methods to specifically orient biological 
molecules on fused silica surfaces were tested.  The first method, which utilized the 
binding of hexa-histidine tags, which are typically added to recombinant proteins for ease 
of purification, to substrate-supported phospholipid membranes containing metal 
chelating lipids, was found to be insufficient for use with TIRF.  However, commercial 
production of phospholipids or of beads containing multivalent chelator heads, which 
have been shown to increase the stability of the interaction between poly-histidine tags 
and chelator moieties by up to 4 orders of magnitude,79 in combination with the use of 
His10 tagged proteins may allow this technique to be used in the future.  The second 
technique, which utilizes the high binding affinity of avidin to biotin, resulted in 
irreversible immobilization of biotinylated protein bound to surface-immobilized 
NeutrAvidin, a modified form of avidin, and was adopted for use with TIRF. 
 Using TIRF, apparent equilibrium constants for the binding of surface-
immobilized LBD-PXR to fluorescently labeled SRC-1 coactivator in the presence and 
absence of rifampicin were determined and are listed in Table 2.3.  The apparent 
association constants were plotted as a function of rifampicin concentration and were 
used to determine the four cyclic rate constants defined by equations 2, 9-11, which are 
listed in Table 2.4.  An approximately 10 fold increase in PXR binding affinity for SRC-1 
was observed at saturating concentrations of rifampicin (K4) as compared to the affinity 
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observed in the absence of rifampicin (K1).  Furthermore, constants for the association of 
PXR to rifampicin (K2) and for the association of SRC-1-bound PXR to rifampicin were 
also determined (K3).  The associated errors in K2 and K4 were generated by the curve 
fitting software, and the error for K3 was determined using standard propagation of 
errors.  As such, the error associated with these constants could be reduced by obtaining 
measurements for the ligand-dependent binding of PXR to SRC-1 at more concentrations 
of rifampicin (to generate more Ka’s) to reduce uncertainty in the fits.  However, DTT, 
which covalently binds in the LBP of PXR, was present in the sample buffer, bringing 
into question the exact values shown in Tables 2.3 and 2.4.  These measurements will be 
repeated in the future using TCEP rather than DTT. 
While numerous studies have qualitatively or quantitatively assessed the 
activation of PXR by ligand binding, the majority of these studies have used methods, 
such as intracellular reporter systems,80 co-immunoprecipitation,81 and competitive 
binding studies,71 that do not readily lend themselves to the study of the kinetic rates of 
molecular interactions.  Subsequently, to date, quantitative studies on the kinetic rates of 
association of PXR to transcriptional coregulators in the presence or absence of ligand, to 
RXRα, or to xenobiotic DNA recognition elements have not been conducted.  To obtain 
kinetic rates for the ligand-dependent binding of coregulators to the LBD of PXR, the in 
vitro system described in this chapter could be studied using total internal reflection in 
combination with fluorescence correlation spectroscopy7, 82 or fluorescence recovery after 
photobleaching.5  In addition, the rate of data acquisition could greatly be increased for 
both equilibrium and kinetic studies through automation using microfluidic devices.11   
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Overall, the experiments presented in this chapter represent the beginning of a 
plethora of studies that could be conducted to quantitatively explore the equilibrium 
binding of PXR using TIRF.  The ligand-dependent binding of PXR to transcriptional 
coactivators could be expanded to include ligands of varying sizes to determine whether 
the structural disordering of PXR that is necessary to accommodate large ligands affects 
the affinity of the receptor for coactivators.  Additionally, the mechanisms of corepressor 
binding to unliganded PXR and of the displacement of bound corepressor through agonist 
binding in the LBP of PXR could be studied using fluorescently-labeled peptide analogs 
of the IDs of nuclear corepressors known to interact with PXR, such as silencing 
mediator of retinoid and thyroid hormone receptors (SMRT).81, 83  Moreover, these 
studies could be repeated using the full sequences of coregulators and of PXR.  As 
nuclear receptors have been shown to preferentially bind to different coregulators,84 the 
association of PXR with several coactivators and corepressors could also be studied.  
Furthermore, the heterodimerization of PXR with RXRα could be studied using PXR and 
fluorescently labeled RXRα, preferably using full length receptors as a recent crystal 
structure of peroxisome proliferated-activator receptor (PPAR), another nuclear receptor 
that exhibits ligand-dependent activation, in complex with RXRα and DNA has shown 
that interactions occur between the ligand binding domain of PPAR and the DNA binding 
domain of RXRα.85  Finally, in vitro equilibrium binding of PXR and PXR-RXRα 
heterodimers to xenobiotic DNA recognition elements could be measured using full 
length receptors.  Ultimately, the information obtained from these in vitro models using 
TIRF could provide valuable insight into the biological functioning of the system and 
could aid in designing in vivo experiments.  
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Figure 2.1 Ligand-Dependent Activation of PXR.  Unliganded PXR binds to the 
promoter region of target genes at xenobiotic response elements (XRE) as a 
heterodimer with RXRα and actively represses target gene activation by recruiting 
transcriptional corepressors (top).  Upon ligand binding, a conformational change in 
the LBD of PXR displaces the corepressor, and PXR recruits transcriptional 
coactivators, leading to the activation of target gene expression and production of 
metabolizing enzymes (bottom). 
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Figure 2.2 Crystal Structure of the LBD of PXR.  The crystal structure of one 
monomer of the PXR-LBD bound to SRC-1 peptide (cyan) and SR12813 (blue) is 
shown above.  From this view, the novel strands β1 and β1’, which form the novel 
homodimer interface, are also visible (green). (Reprinted from reference 17)   
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Figure 2.3 Theoretical TIRF Equilibrium Binding Curves.  Theoretical 
equilibrium binding curves are shown for the ligand-dependent association of surface-
immobilized PXR with fluorescently labeled coactivator in the absence of ligand (a) 
and with increasing concentration of ligand (L) (b).  For these simulations, the curves 
are assumed to be corrected for contributions from background light and from the 
linear dependence of evanescently excited fluorescence on the solution concentration 
of coregulator.  Additionally, constants have been fixed such that K1=1 µM-1, K2=2 
µM-1, K3=20 µM-1, K4=10 µM-1 and QRT=1000. 
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Figure 2.4 Reversible Equilibria of Surface-Immobilized PXR Complexes.  This 
cartoon illustrates the simultaneous equilibrium binding processes occurring among 
surface-immobilized LBD-PXR (R) with coregulators and ligands in solution.  LBD-
PXR binds coregulator or ligand to form complex 1 or complex 2, which is described 
by K1 and K2, respectively.  Additionally, C3 is generated when C1 binds ligand or 
when C2 binds coregulator, giving rise to K3 and K4, respectively.  For TIRF, the 
coregulator is fluorescently labeled, therefore; only binding events that lead to the 
formation of C1 and C3 contribute to the evanescently-excited fluorescent signal at the 
surface.  
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Figure 2.5 Theoretical Ka vs L Curve.  A theoretical Ka vs L curve is presented, 
where Ka are the equilibrium binding constants obtained for surface-immobilized PXR 
to fluorescently labeled coactivator in solution as a function of ligand concentration 
(L).  In this model, ligand binding to PXR increases the affinity of the receptor for the 
coactivator.  This plot was generated using K1=1 µM-1, K2=2 µM-1, K3=20 µM-1 and 
K4=10 µM-1. 
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Figure 2.6 Equilibrium Binding of EGFP-His6 to Ni-DOGS-NTA Lipids.  This 
figure shows a representative binding curve obtained by measuring the evanescently 
excited fluorescence generated by EGFP binding to Ni-NTA-DOGS as a function of 
the solution concentration of EGFP before (a) and after (b) background correction.  By 
fitting the background subtracted data to equation 26, a Kd of 4.43 ± 0.62 µM was 
obtained.  
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Figure 2.7 Western Blotting of B-PXR.  Western blot analysis of b-PXR/BirA 
reaction solution under reducing conditions with anti-biotin-HRP antibodies showed 
successful biotinylation of PXR (+).  To ensure the observed signal was not from 
BirA, a negative control consisting of BirA in PXR buffer with BiomixA and Biomix 
B was run and no signal was observed (-).  Biotinylated protein ladder was run as a 
MW marker (MW).   
MW (–) (+) 
40 kDa 
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Figure 2.9 Ligand-Dependent Binding of PXR.  In this curve, the association 
constants measured for SRC-1 binding to PXR are plotted as a function of the 
corresponding solution concentration of rifampicin.  The plot was fitted to equation 24 
with K2 and K4 as free parameters and K1 equal to the association constant measured 
in the absence of rifampicin.     
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3.1 Introduction 
 
Collagens are the most abundant proteins in mammals, comprising 30% of the 
total protein observed.86  The vertebrate superfamily includes over 50 collagens and 
collagen-like proteins, and to date there are 28 identified types of collagen.  Collagens are 
a major component of the extracellular matrix, which acts as a scaffold for tissues and is 
critical for the biomechanical properties of tissues.  Collagens are substantial constituents 
of skin, tendon, bone, ligament, cornea, and cartilage, and mutations in collagen genes 
cause numerous diseases including osteoporosis, osteoarthritis, tissue fibrosis, and arterial 
aneurysms.87   Collagens also play important roles in cell adhesion and migration during 
growth, differentiation, morphogenesis, and wound healing through interactions with 
other matrix proteins and cell surface receptors.88  Collagens are classified by their ability 
to form supramolecular structures or networks and can be divided into three major 
categories, fibrillar collagens, non-fibrillar collagens, and other collagens such as the 
transmembrane collagens.89, 90    
 The fibrillar collagens, types I-III, V, and XI, are characterized by the presence of 
a 300 nm triple helical domain that in collagen types I-III is flanked on either end by two 
short, globular peptides know as the telopeptides.  Each collagen molecule contains three 
left-handed, helical polypeptide chains containing approximately 1000 amino acids, 
termed α chains, which coil around each other to form a right-handed triple helix.  Each 
α chain consists of repeating G-X-Y sequences, where X and Y can be any amino acid.  
The three α chains in a collagen molecule may be identical or different, depending on the 
type of collagen.88-90  Glycine is required at every third position to allow tight packing 
within the core of the triple helix, stabilizing the molecule through hydrogen bonding of 
72  
the glycines and other residues.91  The X and Y residues are exposed on the surface of the 
molecule and are frequently proline or hydroxyproline, respectively.  These residues also 
stabilize the triple helix by restricting flexibility about the peptide bond and through 
interchain hydrogen bonding.  At high temperatures, hydrogen bonding is disrupted 
causing the polypeptide chains to melt and denature into random coils.  In cells, collagen 
molecules are synthesized and secreted in the form of a soluble precursor, known as 
procollagen, that contains large, globular propeptide domains on the N and C-terminals.  
Upon secretion, the propeptide regions are cleaved by specific proteinases and the 
tropocollagen molecules (triple-helical collagen monomers) then spontaneously self-
assemble into fibrils containing parallel arrays of quarter-staggered molecules, which are 
stabilized by covalent cross-linking.  As adjacent collagen monomers overlap each other 
by 234 amino acids, this gives rise to a repeating axial gap-overlap structure know as the 
D period, which is visible by electron microscopy and appears as an alternating pattern of 
light and dark regions (Figure 3.1).  The characteristic length of the D period ranges from 
64-67 nm, depending on the tissue type, and the length of one collagen molecule is 
approximately 4.4 D-periods.89, 90  Fibril diameters range from 20-500 nm in vertebrates 
and depend on the tissue type and stage of development.92  While the formation of fibrils 
in vivo and in vitro has been the subject of study for over 50 years, major questions 
concerning the mechanisms of fibril assembly, the regulation of fibril length and 
diameter, and the subsequent formation of hierarchical, macromolecular structures from 
fibrillar subunits still remain unresolved.       
Fibrilogenesis in vitro has been widely studied, in most cases using purified, acid-
soluble collagen type I, the most abundant collagen in mammals, from skin or tendon.92  
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When the pH of acid-soluble collagen is adjusted to around neutral and the solution 
warmed to near physiological temperature, collagen fibrils spontaneously form due to an 
increase in solvent entropy arising from burying of surface exposed hydrophobic residues 
within the fibril.  Fibril formation proceeds via a nucleation and growth mechanism.89  
Some evidence suggests that hydrogen bonding between polar residues and other 
electrostatic forces may help drive fibrillogenesis.93  The structure of the resulting fibrils 
is dependent on concentration,94 pH,95, 96 temperature,97 ionic strength,95, 96 ionic 
composition,98 and presence of the telopeptides,99, 100 and these conditions determine 
whether D-periodic or non-banded collagen filaments are observed.101  As such, there are 
several protocols given in the literature for the formation of collagen fibrils with native 
D-periodicity and randomly aligned fibrils.92, 97, 101  As collagen alignment in vivo 
determines biomechanical properties such as tensile strength102 and has been shown to 
direct cell proliferation and migration,103 obtaining collagen gels and films with highly 
oriented collagen fibers is desirable but has proven to be more challenging, often 
requiring the use of strong magnetic fields,104, 105 gravity-driven flow,106 or interstitial 
flow.107  Alternatively, a simple method for aligning collagen gels using small magnets 
and streptavidin-coated magnetic beads has been presented, which resulted in good 
alignment of collagen in 80% of the trials.108  Aligned collagen has also been observed in 
microfluidic channels of less than 100 µm in width when flow was induced prior to 
gelation.109               
Given the structural complexity and functional diversity of collagens, it is not 
surprising that several different types of cell-surface collagen receptors have been 
identified, including integrins, glycoprotein VI, leukocyte-associated IG-like receptor-1, 
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members of the mannose receptor family, and the receptor tryrosine kinases called the 
discoidin domain receptors.88, 110  Receptor tyrosine kinases (RTKs) are a family of 
proteins which convert extracellular stimuli into cellular response.  RTKs are 
transmembrane proteins that contain a large, glycosylated extracellular domain that is 
responsible for ligand binding, a single transmembrane region, and a cytoplasmic domain 
that contains a tryrosine kinase domain.  Depending on the class of receptor, RTK’s exist 
as monomers that undergo dimerization upon ligand binding or exist as preformed 
dimers.  In both systems, a conformational change in the intracellular tyrosine kinase 
domain is induced through ligand binding in the extracellular domain, resulting in 
activation of the receptor through cross phosphorylation of the two tyrosine kinases, a 
process known as autophosphorylation.  In turn, the activated receptor phosphorylates 
other cytosolic proteins, triggering a cascade of signaling processes.111 
 The discoidin domain receptors, DDR1 and DDR2, are unusual members of the 
receptor tyrosine kinase family in that they are not activated by soluble growth factors but 
by fibrillar and non-fibrillar collagens.112, 113   DDR1 has been activated by all collagens 
tested, including types I-VI, and type VIII.2  Until recently when it was shown to be 
activated by collagen type X,114 it was believed that DDR2 was only activated by fibrillar 
collagens, specifically types I-III and V.  Upon binding to collagen, DDRs exhibit 
unusually slow activation with maximal autophosphorylation occurring 90 minutes to 2 
hours after initial stimulation, which is significantly slower than other RTKs that become 
fully activated within minutes.  Heat denatured collagens (gelatins) do not induce 
receptor autophosphorylation, indicating that the triple helical nature of collagen is 
necessary for receptor recognition and activation.2  Phosphorylation of DDRs can be 
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sustained for up to 18 hours after activation, and this, in conjunction with its slow 
activation, suggests that the DDRs may be involved in long term monitoring of the 
extracellular environment rather than mediating acute responses.112  The DDRs regulate 
cell adhesion, proliferation, and remodeling of the extracellular matrix and control the 
expression of matrix metalloproteinases (MMPs), enzymes that degrade components of 
the ECM including collagen.2, 88   
The DDRs are widely and differentially expressed in fetal and adult tissues, as 
well as normal and malignant tissue.2, 115  DDR1 is mostly found in epithelial cells and 
leukocytes, where DDR2 is a mesenchymally (cells that give rise to such structures as 
connective tissues, blood, lymphatics, bone, and cartilage) expressed receptor.  Specific 
examples of DDR function can be observed through knockout studies in mice.  DDR1 
knockouts indicate that this receptor is an important regulator of mammary glands and 
kidneys.  DDR2 knockouts exhibit dwarfism, indicating DDR2 regulates the growth of 
long bones through chondrocyte proliferation.  The DDRs are implicated in several 
diseases including tumor progression, atherosclerosis, inflammation, and tissue fibrosis 
(reviewed in 2).  While many studies have been conducted to understand the role of the 
DDRs in disease, most work has been performed using type I collagen, neglecting the 
contribution of other collagens in disease progression.    
While following the structural paradigm for RTKs, DDR structure differs in 
several ways.  The ligand binding function is a N-terminal, 160 amino acid discoidin 
domain homology region that was first identified in the slime mold protein discoidin I 
from Dictyostelium discoideum.  This homology is found in more than a dozen 
functionally different mammalian proteins, including transmembrane receptors as well as 
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secreted proteins.  This region is followed by an approximately 200 amino acid domain 
unique to DDR receptors, sometimes referred to as the stalk region, whose function has 
yet to be determined.  As in all RTKs, the DDRs have a single transmembrane region 
followed by an unusually large cytosolic juxta-membrane region.  While the function of 
this region is unknown, it has been speculated that this region may play an autoinhibitory 
role contributing to the slow activation of the receptor.  The C-terminal of the protein 
contains a well conserved tyrosine kinase domain.2   To date, crystal structures for the 
DDR discoidin homology and full length receptors have not been elucidated.  
Consequently, it is not yet understood how collagen binding in the ECD by the discoidin 
domain translates into activation in the cytosolic tyrosine kinase domain, however; there 
is evidence to suggest that internalization of the receptor after ligand binding may play a 
role in its activation.116 
Despite the lack of a crystal structure, several studies have been conducted to 
determine the structure of the discoidin domain (DS).  Using known crystal structures 
from proteins containing homologous discoidin domains, such as the C2 domains from 
blood coregulation factors V and VIII, as a reference, the structures of the discoidin 
domains of DDR1 and DDR2 were theoretically modeled.117, 118  Both models predict a 
central eight-stranded β-barrel and four finger-like loops protruding from one side of the 
barrel that are highly conserved between the DDRs.  These structures also implicate three 
of the four conserved loops in collagen binding.  More recently, a NMR study determined 
the solution structure of the discoidin domain of DDR2 and mapped its binding interface 
with a collagen type II fibril by transferred cross-saturation (TCS) methods.119  In 
agreement with previous theoretical structures, overlaying of 20 backbone models shows 
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the discoidin domain contains eight major β strands that are arranged in two anti-parallel 
sheets of five and three, forming a β-barrel with a jellyroll topology commonly observed 
in other DS domains.  Three interconnecting straight segments close the bottom of the β-
barrel core, and the N and C-terminals are connected with a disulfide bridge between 
Cys30 and Cys185.  On “top” of the β-barrel core are six juxtaposed loops (L1-L6), three 
(L1, L2, and L4) of which significantly differ in structure from other DS domains.  With 
the exception of L5, these loop regions form the collagen binding site, which is described 
as a trench with a curved surface.  The overall fold is stabilized by a disulfide bridge 
between Cys73 and Cys177 that links loops L2 and L6 and makes the trench wide and 
hydrophobic.  Mutagenesis and TCS studies revealed that 13 trench residues, which are a 
mixture of hydrophobic and charged amino acids, are essential for collagen recognition 
and binding.  As the DS domains of the DDRs have an overall sequence identity of 59%, 
it is likely that the structure of DDR1 is similar to DDR2 but with minor differences that 
would account for the observed binding preferences for different collagens.  
Concurrently, a comparison of the two sequences indicates that 11 of the 13 residues 
identified as essential to ligand binding are conserved between the two proteins.120 
 In addition to determining the structure of the discoidin domain, recent studies 
have focused on mapping the DDR binding site(s) on fibrillar collagens.  Using deletion 
mutants of collagen type II, which contain three identical α chains, where one of the four 
repeating D-periods was removed, it was determined that the D2 region is required for 
binding and activation of DDR2.121  In a second study, a set of 56 overlapping triple-
helical peptides designed to specifically map the entire triple helical domain of collagen 
II were used to determine specific peptide sequences recognized and bound by DDR2.  
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These studies found that GVMGFO, where O is hydroxyproline, is the minimal collagen 
sequence required for DDR2 binding, however; autophosphorylation studies indicated 
that a longer peptide sequence, GPRGQOGVMGFO, is required for activation of the 
receptor.  This repeat is conserved in collagen type I and III, suggesting that this 
sequence may be a conserved motif recognized by the DDR proteins for collagen 
binding, and is found in the D2 region of collagen II, in good agreement with the 
previous study.120  The ability of these peptides to activate DDR1 was not investigated.  
 While several studies have examined the binding of DDR1 and DDR2 to 
collagen, these studies have provided more questions than answers about the nature of 
DDR-collagen interactions.  Many studies, which use the soluble, extracellular domain 
(ECD) of the DDRs, have indicated that receptor dimerization117 or oligomerization122, 123 
is necessary for collagen binding, however; other studies have observed collagen binding 
by monomeric ECD receptors.118, 119  Despite the plethora of studies conducted, the 
relationship between DDR binding and the structural organization of collagen has largely 
been neglected.  Therefore, the goal of this work is to use TIRF to measure the difference 
in binding affinity between fluorescently-labeled, monomeric and dimeric ECD-DDR2, 
to fused-silica slides coated with either monomeric collagen type I or with aligned or 
unaligned collagen type I fibrils.  As this work is still in progress, this chapter will 
describe the expression, purification, and fluorescent-labeling of ECD-DDR2.  This 
chapter will also include a detailed account of the various methods employed to generate 
fused-silica slides with aligned or unaligned collagen fibrils or collagen monomers, 
which were characterized using fluorescence microscopy and atomic force microscopy 
(AFM).        
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3.2 Materials and Methods 
3.2.1 Materials 
 All chemicals were purchased from Fisher Scientific (Fairlawn, NJ) unless 
otherwise specified.  Deionized (DI) water was generated using a NANOpure® II water 
purification system (Barnstead International, Dubuque, IA).  Acid-soluble collagen type I 
(2.9 mg/mL, 99.9% pure, in acetic acid pH=2) from bovine skin was commercially 
purchased (PureCol™, Inamed Biomaterials) and used in all collagen experiments.  The 
collagen was neutralized on ice immediately prior to use by making 1:1:8 solution of 10x 
MEM pH=5.0 (Sigma-Aldrich, M3024), 0.2 N HEPES pH=9.0, acid-soluble collagen 
(collagenMEM) or was neutralized by dialyzing into PBS (50 mM sodium phosphate, 150 
mM sodium phosphate, 0.01% sodium azide, pH=7.4) overnight at 4°C (collagenPBS).  
All ECD-DDR2 cell lines were provided by Dr. Edie Goldsmith (Department of Cell and 
Developmental Biology, University of South Carolina).     
3.2.2 Collagen Alignment and Characterization 
3.2.2.i Slide Cleaning and Surface Modification 
 Fused silica slides (1” x 1” x 1 mm, cut in house from 3” x 1” x 1 mm slides, 
Quartz Scientific Inc, Fairport Harbour, OH) were cleaned using either detergent 
cleaning, base cleaning, or acid cleaning, and glass microscope slides (Gold Seal® 
Products, Portsmouth, NH) and Fisherbrand cover glasses (No. 1 Circles, 12 mm dia; 
Fisher Scientific) were cleaned in detergent.  Detergent cleaning was carried out by 
boiling slides in a 10% solution of 7X -ICN detergent (MP BioMedicals, Solon, OH), by 
bath sonicating for 30 minutes and by thoroughly rinsing with DI water.  The slides were 
then sonicated in DI water for an additional 30 minutes, were rinsed again, and were 
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dried at 160oC.   Base cleaning was carried out by soaking slides in a solution containing 
120 g of potassium hydroxide dissolved in 120 mL of DI water and diluted to 1 L with 
95% ethanol (AAPER Alcohol, Shelbyville, KY) for 10 minutes, washing with 95% 
ethanol, and then rinsing with DI water until the pH of the solution returned to neutral.  
Acid cleaning was performed by soaking slides in a 3:1 solution of concentrated sulfuric 
acid to 30% hydrogen peroxide for 45 minutes and then rinsed with DI water until a 
neutral pH was obtained.    
Fused silica substrates were surface modified using silane chemistry or using 
poly-L-Lysine.  Poly-L-Lysine slides were made by soaking the slides for 15 minutes in a 
0.01% poly-L-lysine solution (Sigma-Aldrich, St. Louis, Mo) and by rinsing in DI water.  
After base cleaning, fused silica slides were functionalized using a method derived from 
Lom et. al.124 and Bhatia et. al.125  Briefly, the slides were plasma cleaned in argon gas 
for 15 minutes (PDC-3XG, Harrick Scientific, Ossining, NY), sonicated in a 1% (v/v) 
solution of N-2-aminoethyl-3-aminopropyl-trimethoxysilane (EDS) (Sigma-Aldrich) in 
95% ethanol for 2 minutes, were rinsed in 95% ethanol, were rinsed in 0.22 µm filtered 
DI water, and were dried at 125°C for 25 minutes.  After cooling to room temperature, 
the slides were incubated in a 2.5% (v/v) solution of glutaraldehyde in PBS for 1 hour, 
before rinsing with filtered, DI water.  The slides were left to dry overnight at room 
temperature or for 1.5 hours at 60°C.   
3.2.2.ii Aligned Collagen Films 
Aligned collagen films were created by tilting a fused silica slide at a 45° angle 
and placing a rubber cell-scraper approximately 90° relative to the slide and 0.25” from 
the top of the slide.  One hundred to 200 µL of collagen was pipetted onto the slide and 
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allowed to pool along the cell scraper.  The scraper was then slid down the length of the 
slide to induce flow and evenly coat the slide with the collagen mixture.  For collagen 
samples on bare, fused-silica surfaces, slides were illuminated with UV radiation for 10 
minutes in a cell culture hood prior to incubation.  The slides were incubated at 37°C for 
1 hour to allow collagen to gel or 2.5 hours to produce a dried collagen film.  After 
incubation, slides with collagen were attached via double-sided tape (3M Corp., Part No. 
021200-64988) to 3” x 1” x 1 mm glass microscope slides and washed with 600 µL of 
PBS.  The same procedure was used for poly-L-lysine and EDS coated fused silica slides.  
Films were observed for fibril formation using light microscopy. 
3.2.2.iii Unaligned Collagen Films 
 Monomeric, unaligned collagen films were generated by incubating Fisherbrand 
cover glasses (No.1, 12 mm dia) or siliconized glass cover slides (12 mm dia; Hampton 
Research, Aliso Viejo, CA) for 30 minutes at 37°C in a 10 µg/mL collagen type I solution 
in 55 mM sodium citrate pH=4.5, 100 mM sodium chloride buffer.  Slides were rinsed 
with 0.22 µm filtered, DI water and dried under a stream of nitrogen.  Films were 
analyzed by AFM to characterize surface properties (see below).    Films of unaligned, 
collagen type I fibrils were generated by pipetting 100-200 µL of collagenMEM onto fused 
silica substrates that were laid flat and incubating at 37°C for 1 or 2.5 hours.  This 
procedure was repeated using poly-L-lysine and EDS coated fused silica slides.  Slides 
were attached to microscope slides using double-sided tape, were rinsed with 600 µL of 
PBS, and observed under light microscopy.    
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3.2.2.iv Fluorescence Imaging of Collagen Films 
CollagenPBS was diluted to 0.25 mg/mL, 0.5 mg/mL, or 1.0 mg/mL, and 
fluorescein isothiocyanate (FITC) labeled collagen type I (Sigma-Aldrich C4361) was 
added to a final concentration of 1% in each sample.  Aligned and unaligned collagen 
films on EDS coated fused silica slides were generated as described using 200 µL of 
collagenPBS with a 2.5 hour incubation time, attached to glass microscope slides, and 
rinsed with 600 µL of PBS.  Images were obtained using epifluorescence on an 
instrument consisting of an inverted microscope (Zeiss Axiovert 35; 40x water 0.75 N.A. 
objective), an argon ion laser (Innova 90-3, Coherent, Palo Alto, CA) and a charge-
coupled device (CCD) (Photometrics CH250) imaging detector with Photometrics PMIS 
Image 200 Processing Software (Photometrics Inc., Tucson, AZ).  All images were taken 
using an excitation wavelength of 488.0 nm and an appropriate long-pass filter for 
fluorescence detection.  
3.2.2.v AFM Imaging 
Monomeric, unaligned collagen samples were made as described above, and the 
glass coverslips were attached to round, metal disks using double-sided tape.  Films of 
collagen fibrils were formed by adding 20 µL of 0.10 mg/mL, 0.25 mg/mL, or 1.0 
mg/mL collagenPBS to 18 mm round glass coverslips coated with EDS and by incubating 
at 37°C for 2 hours.  The films were rinsed with 0.22 µM filtered, DI water and attached 
to metal disks as described above.  AFM images were captured in air using either a 
Nanoscope III or IIIa (Digital Instruments, Santa Barbara, CA) microscope in tapping 
mode.  Pointprobe Plus Silicon-SPM tips (Agilent Technology, Tempe, AZ) with 
resonance frequencies of approximately 150 to 160 kHz were used for imaging.  Images 
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were collected at a speed of 3 Hz with an image size of 1 µm2 or 4 µm2 at 512 x 512 pixel 
resolution.  Images were analyzed using Nanoscope III (R) v5.12r5 software (Veeco, 
Santa Barbara, CA). 
3.2.3 Expression, Purification, and Characterization of DDR2 
3.2.3.i Cell Lines and Culture 
 Briefly, the entire ECD of mouse DDR2 (amino acids 1-399) was cloned with a 
C-terminal 6x His tag (ECD-DDR2-His) into human embryonic kidney 293 cells (HEK 
293).  A second cell line was generated in which Cys348 of the ECD was mutated to 
another amino acid and was expressed in HEK293 cells (mECD-DDR2-His).  
Additionally, a fusion protein containing the ECD of DDR2, a 6x His tag, and a C-
terminal enhanced green fluorescent protein (EGFP) (ECD-DDR2-EGFP) was expressed 
in Chinese hamster ovary cells (CHO).  All cell lines excreted soluble ECD-DDR2 
proteins and were cultured in DMEM/F-12 supplemented with 10% fetal calf serum, 800 
µg/mL of Geneticin, 100 units/mL penicillin, 100 µg/mL streptomycin, 1 mM sodium 
pyruvate, and 2 mM L-glutamine (all reagents were Gibco® brand; Invitrogen Corp., 
Carlsbad, CA) in a humidified incubator at 37°C with 5% CO2.        
3.2.3.ii Purification of DDR2 
 Soluble ECD-DDR2 proteins were purified using nickel nitrilotriacetic acid (Ni-
NTA) or affinity column chromatography.  Media from cell culture was spun at 5000 rpm 
in 50 mL conical tubes to remove cell debris prior to being passed through a 0.22 µm 
bottle-top filter (Corning Inc., Lowell, MA).  For Ni-NTA chromatography, the pH of the 
media was adjusted by adding 50 mM sodium phosphate pH=8.0, 150 mM sodium 
chloride, and 10 mM imidazole (final concentrations) and passed over Ni-NTA agarose 
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(Qiagen, Valencia, CA) equilibrated in 50 mM sodium phosphate pH=8.0, 300 mM 
sodium chloride, and 20 mM imidazole (wash buffer) using gravity-flow columns.  Wash 
buffer equal to twice the volume of media was then passed through the column, before 
eluting with buffer containing 50 mM sodium phosphate pH=8.0, 300 mM sodium 
chloride, and 250 mM imidazole.  For affinity chromatography, anti-DDR2 antibodies 
(SC-7555, Santa Cruz Biotechnologies Inc., Santa Cruz, CA) were coupled to cyanogen 
bromide-activated-Sepahrose® 4-B agarose following the manufacturer’s protocol 
(Sigma-Aldrich, St. Louis, MO).  The resulting resin was equilibrated in a 50 mM Tris 
pH=7.5, 150 mM sodium chloride, 0.1% Tween-20 buffer (buffer I) in a gravity flow 
column prior to passing media through the column.  The column was then washed, with a 
volume equal to that of the media for each, with buffer I and buffer II (50 mM Tris 
pH=7.5, 500 mM sodium chloride, 0.1% Tween-20) and was eluted with a 100 mM 
sodium acetate pH=4.0, 500 mM sodium chloride buffer.  For both methods, fractions 
containing ECD-DDR2 were pooled, dialyzed into PBS, and concentrated using Amicon 
Ultra MWCO 10,000 (Millipore, Billerica, MA).  Concentration of the samples was 
determined using Bio-Rad protein assay with BSA standards (Bio-Rad Laboratories Inc., 
Hercules, CA).  The purity was confirmed by SDS-PAGE using 7.5% or 10% Tris-HCl 
ready gels with silver staining (GE Healthcare, Piscataway, NJ).          
3.2.3.iii Western Blotting 
To confirm production of ECD-DDR2, samples with a concentration of 1 µM 
total protein were diluted 1:1 with 2x SDS-Loading Buffer (250 mM Tris-base pH=6.9, 
40% (v/v) glycerol, 9.25% (w/v) SDS, 0.1% bromophenol blue) with or without β-
mercaptoethanol (10% (v/v)) and loaded onto a 10% Tris-HCl ready gel with Magic 
85  
Mark® molecular weight marker (MW) (Invitrogen).  The gel was run at 120 V for 20 
minutes, then at 180 V until complete, before transferring to a PVDF membrane in 20 
mM Tris-HCl, 20 mM glycine buffer at 350 mA for 60 minutes at 4°C.  The membrane 
was blocked in 10 mM Tris pH=7.5, 150 mM sodium chloride, 5% (w/v) non-fat dried 
milk, and 0.05% Tween-20 buffer (TBST) for 45 minutes, incubated with 1:1000 dilution 
of 1506 antibody (rabbit anti-(ECD-DDR2) antibody produced in E. Goldsmith’s lab) in 
TBST for 1 hour, and washed three times for 15 minutes with TBST.  The blot was then 
incubated with 1:2000 dilution of HRP-conjugated goat-anti-rabbit antibody (Zymed® 
Laboratories, Inc., San Francisco, CA) in TBST, was washed an additional three times for 
15 minutes with TBST, and was thoroughly washed with DI water to remove the milk.  
The blocking, incubation, and washing steps were all completed at room temperature.  In 
the dark room, the blot was incubated with ECL detection chemical (Pierce 
Biotechnology, Rockford, IL) for 2 minutes and was exposed to Amersham Hyperfilm 
ECL photosensitive film (GE Healthcare) for 16 seconds.  The film was developed using 
standard procedures. 
3.2.3.iv Dynamic Light Scattering 
To accurately determine the molecular weight, ECD-DDR2 samples were 
concentrated to 1.0 mg/mL using Micron YM-10 concentrators (Millipore) and were run 
on a Wyatt DAWN EOS light scattering instrument interfaced to an Amersham 
Biosciences ÄKTA FPLC with a Superose™ 12 column at a flow rate of 0.25-0.5 
mL/min in PBS with or without 5 mM DTT.     
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3.2.4 FPLC 
 To separate monomers from dimers, ECD-DDR2 samples were concentrated to 1 
mg/mL using Micron YM-10 concentrations (Millipore) and were 0.22 µm filtered using 
Ultrafree®-MC centrifugal filters (Millipore).  Approximately 0.5 mL of sample was 
loaded onto a Superose™ 12 (10/300 GL, GE Healthcare) or a Superdex™  200 (10/300 
GL, GE Healthcare) column equilibrated in PBS or PBS with 5 mM DTT using an 
ÄKTA FPLC UPC-900 (GE Healthcare) with a constant flow rate of 0.5 mL/min.  One 
milliliter fractions were collected and analyzed using SDS-PAGE with 10% Tris-HCl 
gels and silver staining.   
3.2.5 Fluorescent Labeling 
 ECD-DDR2 and IgG Fab (Zymed® Laboratories, Inc.) were labeled with Alexa 
Fluor® 514 carboxylic acid, succinimidyl ester (A514) according to manufacturer’s 
protocols (Molecular Probes, Carlsbad, CA).  Protein was dialyzed into PBS in the 
presence or absence or 10-fold molar excess TCEP, was concentrated between 0.4 to 0.8 
mg/mL and, after addition of 20 to 25-fold molar excess of fluorophore to each sample, 
allowed to react at room temperature (Fab) or 4°C (for ECD-DDR2) for 2 hours.  To 
remove the free dye, samples were run down a G-25 Sephadex® column (Sigma-
Aldrich), and eluted fractions were pooled and dialyzed overnight at 4°C into PBS.  The 
labeling ratio was determined spectrophotometrically using CF280=0.18, where CF is 
correction factor (ελ=280/ελ=517), and ελ=517=80,000 M-1cm-1 for Alexa Fluor® 514, and 
ελ=280=75,000 M-1cm-1 for Fab.  By determining the concentration of ECD-DDR2 using 
Bio-Rad Protein Assay and BSA standards and by taking the Aλ=280 of same sample, the 
ελ=280 for DDR2 was calculated to be 47,000 M-1cm-1.    
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3.2.6 TIRF Microscopy  
3.2.6.i Positive and Negative Controls 
 Positive control slides of aligned collagen films were made and tested for 
consistency.   The films were generated using 200 µL of collagenPBS incubated on EDS-
coated, fused-silica slides for 2.5 hours.  The slides were attached to glass microscope 
slides and washed with 600 µL of PBS.  To block non-specific absorption, 100 µL of 10 
mg/mL ovalbumin were added to the slides and incubated for 30 minutes at room 
temperature.  Prior to TIRF measurements, 150 µL of 1 µM ECD-DDR2-A514 in 10 
mg/mL ovalbumin were added, and slides were sealed with vacuum grease.        
Three different types of samples were evaluated for their use as negative controls 
for TIRF microscopy.  EDS-coated, fused-silica slides were attached to glass microscope 
slides using double-sided tape, and 100 µL of a 50 mg/mL solution of bovine serum 
albumin (BSA) (Sigma-Aldrich) were pipetted between the slides.  The slides were 
incubated at room temperature for 1 hour.  Aligned collagen slides were generated as 
described above by incubating 150 µL of collagenPBS on an EDS-coated, fused-silica 
slide for 1 hour at 37°C.  Additionally, 150 µL of a 2% solution of gelatin type B from 
bovine skin (Sigma-Aldrich) were pipetted onto a fused-silica coverslip, incubated at 
37°C for 1 hour, and attached to a glass microscope slide with double-sided tape.  All 
samples were washed with 600 µL of PBS prior to adding 100 µL of 10 mg/mL 
ovalbumin, which was allowed to incubate for 30 minutes at room temperature.  To each 
slide, 150 µL of 1 µM Fab-A514 in 10 mg/mL ovalbumin were added, and slides were 
sealed with vacuum grease in preparation for TIRF measurements.   
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3.2.6.ii Instrumental Setup  
Through prism total internal reflection experiments were carried out on the 
instrument described previously.  Fluorescence intensity measurements were collected for 
30 seconds using a single-photon counting photomultiplier (RCA C31034A, Lancaster, 
PA) interfaced to a PC-based correlater board (model 5000/E, ALV).  All experiments 
were conducted at an excitation wavelength of 514 nm, a laser power of 50 µW, and at 
25oC.   
 
3.3 Results 
3.3.1 Aligned and Unaligned Films of Collagen Fibrils 
 As seen using light microscopy, aligned and unaligned films of collagen fibrils 
did not form on bare fused-silica surfaces, even with UV cross-linking.   Upon further 
investigation, it was discovered that immediately after incubation loosely adhered, thin 
films of collagen fibrils were on the surface, but these films detached and were rinsed 
away during subsequent wash steps.  This process was found to be independent of the 
method used to clean the slides.  Coating the fused-silica slides with poly-L-lysine 
resulted in only patchy coverage of collagen fibrils.  Increasing the amount of collagen 
that was incubated on the slide also did not significantly increase the observed surface 
coverage.  Fused-silica slides that were covalently bound with N-2-aminoethyl-3-
aminopropyl-trimethoxysilane (EDS) showed improved and complete surface coverage 
when incubated at 37°C for 1 and 2.5 hours, respectively.  Dialyzing collagen into PBS 
overnight at 4°C rather than neutralizing immediately prior to film formation was also 
found to improve film coverage.  However, increasing the incubation time resulted in 
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partial alignment of the unaligned films due to rings forming as the sample dehydrated.  
These rings were not observed in aligned collagen samples, and the difference is most 
likely due to the angle at which the slides were incubated.  Therefore, a slightly different 
procedure that keeps the sample hydrated throughout the entire incubation period will 
most likely need to be used for unaligned films of collagen fibrils.              
3.3.2 Fluorescent Imaging of Collagen Fibril Films 
 To verify the alignment of collagen fibrils, collagen films that were 1% labeled 
with FITC were made on EDS treated fused-silica slides and observed using 
epifluorescence.  As shown in Figure 3.2, for aligned collagen films light and dark 
parallel stripes, which increased in width as the concentration of collagen increased, were 
observed.  The stripes extended along the entire length of the sample, indicating complete 
surface coverage.  Similar morphology was observed for unaligned films, indicating that 
collagen fibril alignment was occurring in these samples, as previously indicated by light 
microscopy.         
3.3.3 AFM Imaging 
 To characterize the molecular organization of collagen in unaligned films, atomic 
force microscopy (AFM) was used to probe collagen films generated by adsorption of 
acidic or neutralized collagen on bare, siliconized, or EDS-treated glass surfaces.  To 
generate collagen fibrils, unaligned films were made on EDS coated slides using solution 
concentrations of 0.10 mg/mL, 0.25 mg/mL, or 1.0 mg/mL of collagenPBS.  At a 
concentration of 1.0 mg/mL, surface features could not be identified due to too much 
protein being adsorbed onto the surface.  For samples made with 0.10 mg/mL of 
collagen, short fibrils with a banded appearance signifying D-periodicity were observed 
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on the surface with heights on the order of 10 nm.  At a concentration of 0.25 mg/mL, 
extended collagen fibrils exhibiting D-periodicity with lengths on the order of several 
microns and with observed heights in the range of 50 to 75 nm were seen in addition to 
the short, banded fibrils, as shown in Figure 3.3 (a) and (b).   Non-banded, filamentous 
collagen fibrils were not present in any of the images.  Together, these results indicate 
that the procedures used to generate collagen films produce fibrils in their native D-
periodic form.   
Collagen films produced from adsorbing collagen at an acidic pH onto siliconized 
and untreated glass surfaces had very different surface morphologies than collagen films 
generated at neutral pH.  As seen in figure 3.3 (c), the surface morphology of siliconized 
glass that was incubated in 10 µg/mL of collagen in 55 mM sodium citrate pH=4.5, 150 
mM sodium chloride buffer is characterized by branching, filamentous structures.  
Surface analysis revealed a mean height of 2.80 ± 1.45 nm overall, with heights of 4 to 6 
nm in the thicker branches (i.e. lighter).  As a collagen molecule has a diameter of 1.5 
nm, this roughly corresponds to 2 to 3 monolayers of collagen being absorbed onto the 
surface.  For the untreated glass surfaces, a mean height of 1.67 ± 0.6 nm was observed, 
roughly corresponding to a monolayer of collagen, and the surfaces appeared to be more 
evenly coated.  AFM images of bare glass (data not shown) did not show any defining 
surface characteristics and had a mean roughness of approximately 0.2 nm.  Overall, 
these images show that non-specifically adsorbing collagen at an acidic pH gives surface 
coverage on the order of a few monolayers of collagen.   
 
91  
3.3.4 Expression of DDR2 
 Of the three cell lines cell lines that were created to produce the ECD of DDR2, 
only one cell line, ECD-DDR2-His, gave appreciable expression of the excreted, soluble 
receptor, which was purified from the cell media using Ni-NTA chromatography.  SDS-
PAGE with silver staining and western blotting analysis of the purified DDR2 revealed 
that it was expressed as a monomer, dimer, and aggregate mixture as shown in figure 3.4 
(a) and (b).  Previous reports have indicated that the ECD of DDR2 was expressed as a 
monomer or dimer, but none of these studies reported seeing a mixture of different 
species.  To the contrary, several studies reported that oligomerization of the receptor 
required the use of C-terminal fusion proteins that were used along with covalent cross-
linking agents to permanently bind the monomers or dimers together.117, 123, 126  As 
addition of a large excess of reducing reagent resulted in removal of higher molecular 
weight species (see Figure 3.4 (c)), it was concluded that a covalent dimer was formed, 
which was supported by the fact that the amino acid sequence of the ECD of DDR2 
contains an odd number (7) of cysteines.  Size exclusion chromatography with in-line 
multi-angle light scattering (SEC-MALS) and refractive index detectors confirmed the 
presence of 3 molecular species at 60 kDa (monomer), 120 kDa (dimer), and ~1000 kDa 
(aggregate containing approximately 15-17 monomers) with the monomer as the 
prevalent molecular species.  Interestingly, SEC-MALS experiments that were repeated 
with 5 mM DTT in the running buffer did not result in removal of the higher molecular 
weight species, nor was a significant shift in the relative concentrations of the molecular 
species observed.  Representative SEC-MALS chromatograms are shown in Figure 3.5. 
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 As the initial SEC-MALS data resulted in near base-line separation of the three 
ECD-DDR2 species, attempts were made to separate the monomer from the dimer using 
FPLC with size exclusion chromatography.  However, base-line resolution of the 
monomer and dimer peaks could not be achieved using the same buffer conditions with 
either a Superdex™ 200 column or a Superose™ 12 column.  Addition of 5 mM DTT did 
not improve resolution, which was consistent with previous observations, but it did result 
in a small reduction in the dimer and aggregate peaks (Figure 3.6).  Additionally, 
separated fractions stored at 4°C reverted to the original monomer, dimer, aggregate 
mixture even when stored under mild reducing conditions.  Figure 3.7 shows a gel, which 
was run three days after separation, of FPLC fractions stored in reducing buffer and run 
in loading buffer without β-mercaptoethanol.  Consequently, separation of the monomer 
and dimer has not yet been achieved.  
3.3.5 TIRF Microscopy 
 Control slides consisting of aligned collagen films immobilized on EDS treated 
fused-silica slides attached to microscope slides were blocked with 10 mg/mL ovalbumin 
in PBS to prevent any areas that may not have been fully saturated with collagen from 
non-specifically adsorbing fluorescently-labeled proteins.  To evaluate their applicability 
in TIRF measurements, a solution of 1 µM Fab labeled with Alexa Fluor® 514 with 10 
mg/mL ovalbumin in PBS (Fab-A514) was added to each sample, and the slides were 
mounted on the stage of a TIRF microscope.  Upon excitation at 514 nm, evanescently 
excited fluorescence with the characteristic oval shape seen in through-prism TIRF was 
observed.  The spot appeared more diffuse than what is typically observed with other 
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samples, such as fluorescently-labeled phospholipid bilayers, but was sufficient for TIRF 
measurements.   
To assess the sample to sample reproducibility required for the determination of 
binding constants with TIRF microscopy, three sets of two slides were prepared using the 
method described above with 1 µM ECD-DDR2 labeled with Alexa Fluor® 514 in 10 
mg/mL ovalbumin in PBS used in place of the Fab-A514 solution.  Using TIRF, 
fluorescent intensities were collected for nine different areas on each sample and were 
used to calculate a percent standard deviation (% SD) of the average for each slide.  For 
each sample set, the percent difference in the average fluorescent intensity of the two 
slides was also determined, and the results are summarized in Table 3.1.  The % SD for 
each slide was found to be less than 8%, indicating low variability in ECD-DDR2 surface 
binding across a given sample.  As significant changes in the surface density of receptor 
binding sites across a sample would increase the % SD, the low % SD observed also 
indicates that the density of collagen on the surface of each slide is fairly uniform.  The 
percent difference between the average fluorescence intensities of “duplicate” slides 
made with the same materials on the same day can be used to evaluate the inter-sample 
reproducibility.  As the largest variability in TIRF measurements arises between duplicate 
samples, the observed percent differences, which ranged between 2.6% and 22.6%, were 
acceptable.  Under ideal conditions that would yield binding constants with very low 
error, the percent difference between duplicate slides would approach zero.  
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Table 3.1 Evaluation of Sample Reproducibility 
                            
  Day 1  Day 2  Day 3  
              
 Sample A  B  A  B  A  B  
              
% SD  1.7  9.5  7.3  5.4  4.7  7.4  
% Difference  2.6  22.6  11.5  
                            
 
As the fluorescence signal increases linearly with increasing solution 
concentration of fluorescent molecules in TIRF, negative controls in which fluorescent 
molecules in solution do not associate with the surface are required for binding 
experiments.  To create negative controls for ECD-DDR2 binding experiments, this 
condition was simulated using the same collagen surfaces generated for positive control 
measurements, but Fab-A514 was used in place of ECD-DDR2-A514.  As TIRF 
measurements are dependent on the relative fluorescence intensity, a correction factor 
based on the differences in the labeling ratios of the protein samples must be determined 
and applied to negative controls.  To circumvent this problem, the fused-silica surfaces 
were coated with gelatin or BSA, proteins to which ECD-DDR2 does not bind, and TIRF 
measurements were taken using the Fab-A514 solution.   
The normalized average fluorescence intensities for the three systems are 
presented in Table 3.2.  As data were collected using the same concentration of a given 
sample of Fab-A514 and with the same excitation intensity, it is surprising that the 
average fluorescence intensities for gelatin and BSA coated fused-silica slides were much 
less than that of the collagen slides.  These differences could result from many factors, 
such as Fab-A514 non-specifically binding to the sample or collagen coated slides 
exhibiting different evanescent wave profiles, and indicate that developing negative 
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controls will require more investigation.  At present, even with the need to correct for 
differences in the labeling ratio, replacing ECD-DDR2 with Fab appears to be the best 
method for generating negative controls of the methods tested.   However, a promising 
option would be to prevent DDR2 binding to immobilized collagen films by adding a 
large excess of a molecular species that binds in the ligand pocket of DDR2 with a very 
high affinity, such as triple-helical peptide analogs that contain the collagen recognition 
sequences required for DDR2 binding,120 or that binds to DDR2 in a manner that blocks 
its binding pocket.  Alternatively, DDR2 binding sites on collagen could be blocked by 
adding a large excess of a molecular species that binds to collagen at or overlapping the 
DDR2 recognition sites.  Solid phase binding studies have also used collagen type IV, 
since DDR2 does not bind to this type of collagen, in place of collagen type I as a 
negative control.   
 
 Table 3.2 Negative Controls  
        
 Surface Coating 
 Collagen Gelatin BSA 
    
Normalized Fluorescence 1.0 0.3 0.2 
Standard Deviation 0.1 0.06 0.02 
        
    
 
3.4 Discussion 
While conducting this work, many reports characterizing the interaction of the 
DDRs with collagen have been presented in the literature.  Original binding studies of 
DDRs with collagen indicated that the DDR2 is activated by soluble and fibrillar 
collagens,112, 113 but these studies failed to closely monitor the organization state of 
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collagen.  However, more current investigations have focused on characterizing the 
binding of DDR2 to type I collagen monomers (MC).  Using AFM, studies have shown 
that ECD-DDR2 binds to MC with 95% of the binding events occurring between a single 
ECD-DDR2 dimer and collagen.  From this binding data, it was speculated that there may 
be two preferred binding sites on collagen, but the exact location of these sites could not 
be determined due to the fact that the collagen monomers were partially cleaved through 
pepsin digestion.126  Furthermore, a study in which a peptide library was used to map the 
surface binding sites on collagen II for DDR2 saw that these triple-helical peptide 
analogs are capable of activating DDR2 with the same slow rate of phosphorylation 
characteristically observed with collagen.  These peptides do not associate in solution to 
form supramolecular structures, suggesting that monomeric collagen is sufficient for 
receptor activation.120  Investigations with soluble ECD-DDR2 proteins123 and with over 
expression of surface anchored DDR2 receptors that lack that the kinase domain127 have 
shown that DDR2 is capable of inhibiting fibrillogenesis of type I collagen in solution 
and in cell culture based assays.  Collagen fibrils formed in the presence of DDR2 lacked 
native D-periodicity and had reduced radii as compared to fibrils formed in control 
measurements.123, 127  As similar results were seen for DDR1,122 these studies indicate 
that DDRs plays a significant role in vivo in the direct regulation of fibrillogenesis 
through collagen binding. 
Other studies have characterized the interactions of cells expressing DDR2 with 
collagen type I in its fibrillar state (FC).  When grown in contact with FC, proliferation of 
tumor cells is inhibited, which can be relieved through silencing of DDR2 expression, 
and an increase in DDR2 tyrosine phosphorylation was observed.  Conversely, tumor 
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cells grown on films of monomeric type I collagen did not show increased activation of 
DDR2 and exhibited normal growth.  This indicates that DDR2 participates in mediating 
tumor cell cycle arrest through direct receptor-induced signaling.128  Contrary to findings 
for tumor cells, non-malignant cells, such as skin fibroblasts and hepatic stellate cells, 
when grown on FC and Matrigel, a commercial heterogeneous mix of collagens that 
forms fibrillar structures after incubation at biological temperature, have exhibited 
increased cell proliferation through DDR2 activation.129, 130  Consequently when activated 
by FC, DDR2 may play a duel role as a growth inhibitor or stimulator depending on the 
cell type, but currently the mechanisms by which these processes occur are not well 
understood.  
While many studies have indicated that the molecular organization of collagen is 
important for DDR2 recognition in vivo, a side-by-side, quantitative comparison of 
DDR2 binding to collagen in its MC versus FC forms has not been conducted to date.  
The in vitro binding of soluble ECD-DDR2 proteins has been widely studied in the 
literature with variable results, but these studies have been mostly been focused on the 
oligomerization state of DDR2 necessary for binding.  Initial studies that used solid phase 
binding assays indicated that ECD-DDR2 binding of collagen type I and II only occurred 
for dimerized forms of ECD-DDR2 with half-maximal binding occurring at 
concentrations of approximately 20 nM ECD-DDR2.117, 121  These studies also showed 
that the DS domain alone was sufficient for collagen binding when dimerized.117  Other 
studies, again using solid phase binding assays126 or surface plasmon resonance 
spectroscopy,123 indicated that ECD-DDR2 clustering or oligomerization was necessary 
to see measurable binding and, for clusters of DDR2 containing 4 ECD units, found a 
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dissociation constant (Kd) of 0.3 nM for collagen type I.123  Eventually, a monomeric 
DDR2 that consisted of only the DS domain was found to bind collagen type II with a Kd 
of 25 µM.119  While these studies have taken great care to classify the oligomerization 
state of ECD-DDR2, the dependence of ECD-DDR2 binding strength on the 
organizational state of collagen has largely been ignored.  This, along with the fact that 
the collagens were isolated from varying sources and were extracted using differing 
protocols, may account for the large discrepancy in the reported measurements.  As such, 
the goal of this study was to use total internal reflection fluorescence microscopy (TIRF) 
to measure the binding of fluorescently-labeled ECD-DDR2 in solution to films of 
collagen type I fibrils or monomers that are immobilized at the solid-solution interface.   
Through the work described in this chapter, considerable progress towards using 
TIRF to study the interactions of ECD-DDR2 with collagens has been made.  Accurately 
measuring equilibrium binding constants with TIRF microscopy requires the use of 
samples with a consistent density of surface binding sites at the solid-solution interface.  
For ECD-DDR2 binding studies, this required the development of reproducible methods 
to coat fused-silica slides with collagen type I films, which was successfully 
accomplished for aligned, fibrillar and monomeric collagen films, as confirmed by 
fluorescence imaging, TIRF microscopy, and/or AFM.  Light microscopy and 
fluorescence imaging showed partial alignment of unaligned collagen films, therefore; a 
better procedure for creating these films needs to be developed.  The use of negative 
controls that account for background fluorescence, which increases linearly with the 
solution concentration of fluorescently-labeled molecules, is also required for accurate 
measurement of binding constants with TIRF microscopy.  An acceptable method for 
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making negative controls, which involves replacing ECD-DDR2-A514 with Fab-A514, 
was also explored.  Consequently, TIRF experiments for the binding of ECD-DDR2 to 
films of aligned, fibrillar or monomeric collagen type I are close to realization. 
 Attempts to separate the naturally occurring mixture of ECD-DDR2 monomer, 
dimer, and aggregate were unsuccessful.  Recent evidence from the literature indicates 
that in vivo the DDRs exists as dimers and monomers in the plasma membrane of cells. 
However, upon collagen stimulation, the fraction of dimerized receptors does not 
increase, and only dimeric receptors exhibit phosphorylation, suggesting that monomeric 
receptors do not participate in the processes leading to signal transduction.116, 131, 132  As a 
1000-fold difference in the binding strength for collagen type II has been observed 
between dimeric121 and monomeric states of ECD-DDR2,119 separation of the two may 
not be required to determine dimer binding constants, because in TIRF the signal that 
arises from surface associated binding is dominated by the molecular species with the 
strongest equilibrium association constant.  As the binding from aggregates, which occur 
in vivo only after activation,116 has been shown to be approximately 100 fold stronger123 
than for dimers of ECD-DDR2,117 separation of these two species may be necessary.  Due 
to the large size difference, this separation could most likely be accomplished with 
filtering or clarification using ultra-centrifugation.  Additionally, the occurrence of the 
molecular aggregate increased with concentrating (data not shown), therefore at low 
protein concentrations the aggregate may not be present to a significant percentage in 
ECD-DDR2 samples.  Additionally, if future evidence implicates DDR2 monomers in 
significant biological roles, monomeric ECD-DDR2 could be generated through genetic 
cloning by removal of the stalk region, as DDR2 proteins containing only the DS domain 
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have been shown to retain collagen binding117, 119 and as dimerization has been shown to 
occur through the ECD stalk region in DDR1,132 which is homologous to the stalk region 
of DDR2.  Currently, dimerization is not believed to induce a conformational change that 
increases binding affinity in the DS domain,120 therefore; it may also be desirable to 
produce monomer only solutions of ECD-DDR2 to altogether avoid the need for 
separation of the oligomerization states.  Since a mutation in DDR1 similar to the one 
made in the mECD-DDR2-His plasmid was shown to abolish receptor dimerization,132 
work to increase the protein expression in this cell line could achieve this goal.        
 Overall, many new avenues exist for studying the interactions of ECD-DDR2 
with collagen using TIRF microscopy.  Pure collagen type I was initially selected for 
these studies because it is the most abundant collagen found in mammals and has widely 
been studied in the literature.   However, even in tissues that are predominately collagen 
type I other types of collagen are found, notably types III and V.  For example, in the 
case of the cornea, coassembly of collagen type V into collagen type I fibrils are believed 
to be one of the factors that regulate the small, uniform fibrillar diameters observed in 
this tissue.90  Additionally, in developmental processes where DDRs are believed to play 
a key role in regulation of the ECM, multiple types of collagen exist and undergo changes 
in density, for example as seen in heart valve development.115, 133  Therefore, classifying 
the interactions of DDR2 with other types of collagens or with mixtures of collagens is a 
direction that, as of yet, largely remains unexplored.  As the binding of DDRs has been 
found to be dependent on the level of glycosylation in collagen,112, 128 this represent 
another area for future study.  Furthermore, there are no studies on the in vitro kinetic 
rates for the interaction of the DDRs with collagen, which could potentially be studied 
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with TIRF through combination with fluorescence recovery after photobleaching or 
fluorescence correlation spectroscopy.       
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Figure 3.1 Structure of collagen fibrils. (a) TEM image of collagen type I fibrils 
isolated from mammalian lung tissue.  The bar in the left hand corner represents 50 
nm. (b) Cartoon rendering of a collagen fibril showing the characteristic, 
alternating light/dark pattern resulting from gap (dark) and overlap (light) regions 
of the fibril (top).  Each dark box represents a collagen molecule, aligned N to C 
from left to right, arranged in the staggered, parallel array conformation found in 
fibrils with D-periodicity (middle).  A zoomed in image of the D period shows the 
234 amino-acid overlap between adjacent, triple-helical collagen molecules 
(bottom). [Figure (a) was released to the public domain by Louisa Howard (2006); 
http://remf.dartmouth.edu/images/mammalianLungTEM/source/9.html]      
a 
b 
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Figure 3.2 NMR Structure of the Discoidin Domain of DDR2 (side view) shows 
the jellyroll topology formed by the β-sheets (orange).  The collagen binding site (not 
labeled) is located on top of the structure. (From ref 35; RCSB PDB ID: 2z4f)         
N 
C 
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10 µM 
Figure 3.3 Epifluorescent Image of Aligned Collagen Fibrils.  A 1.0 mg/mL 
solution of collagen type I with 1% FITC labeling was absorbed onto an EDS treated 
fused-silica coverslip, attached to a microscope slide, and washed with PBS.  The 
image was collected with a CCD camera at 40x magnification on an inverted 
microscope with epifluorescence using an excitation wavelength of 488 nm.       
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Figure 3.4 AFM Images of Collagen Films.   EDS treated glass surfaces after non- 
specific adsorption of a 0.25 mg/mL solution of collagen neutralized in PBS results in 
(a) small fibrils (4 µm2, 15 nm height scale) and (b) micron sized fibrils with clear D-
periodicity (4 µm2, 70 nm height scale).  Adsorption of acidic collagen results in short, 
filamentous morphology of collagen molecules on (c) siliconized glass (1 µm2, 10 nm 
height scale) and (d) bare glass (1 µm2, 3 nm height scale).  All images were taken in 
air.      
b a 
d c 
106  
 
 
 
 
 
 
 
 
Figure 3.5 SDS-PAGE and Western Blotting of ECD-DDR2.  (a) SDS-Page with 
silver staining of a 10% Tris-HCl gel showed multiple bands for the purified ECD-
DDR2 samples under non-reducing conditions. (b) Western blot analysis under non-
reducing conditions with anti-ECD-DDR2 primary antibodies indicated that ECD-
DDR2 oligomerizes.  (c) Western blot analysis probed with anti-ECD-DDR2 primary 
antibodies of the same sample as in (b) but under reducing conditions showed loss of 
high MW products and provides evidence for covalent interactions.         
MW   DDR2 
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Figure 3.6 SEC-MALS of ECD-DDR2.  FPLC chromatograms with multi-angle light 
scattering (–) and refractive index (–) detection of ECD-DDR2 samples run in PBS (a) 
or in PBS with 5 mM DTT (b).  The black lines indicate the widths used to calculate 
peak area for MW determination.  From left areas the boxed peaks correspond to the 
molecular aggregate, dimer, and monomer.     
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b 
a 
Figure 3.7 FPLC Chromatograms of ECD-DDR2 Samples.   FPLC chromatograms 
with UV detection of 1.0 mg/mL ECD-DDR2 samples run at a flow rate of 0.5 mg/mL 
in PBS with 5 mM DTT (a) and in PBS (b) on a Superdex™ 200 column.  From left to 
right, the three arrows in each chromatogram indicate aggregate, dimer and monomer 
peaks.  A slight reduction in the peak areas of the aggregate and dimer can be 
observed in (a) as compared to (b).  
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Figure 3.8 SDS-PAGE of FPLC Fractions.  SDS-PAGE on a 10% Tris-HCl gel with 
silver staining of successive FPLC fractions collected in PBS with 5 mM DTT diluted 
1:1 with non-reducing 2x SDS-Loading Buffer revealed that monomeric and dimeric 
forms of ECD-DDR2 were present in all samples 3 days after separation.  The top 
arrow indicates DDR2 molecular aggregate, which was detected in only the first four 
fractions analyzed. 
120 kDa 
60 kDa 
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4.1 Introduction 
Translational diffusion is central to most biological processes especially in 
prokaryotic cells.  Since these cells lack the motor proteins and developed cytoskeletal 
networks of higher organisms, diffusion is often their primary source of intracellular 
movement.  Measuring diffusion in micron-sized structures, however, is challenging 
because of their small size compared to classical optical resolution.   
The primary method for measuring diffusion in biological systems, fluorescence 
recovery after photobleaching (FRAP) with a small focused spot,134, 135 suffers from the 
fact that the smallest focused laser spot used for illumination is not much smaller than an 
Escherichia coli cell or an organelle.136  Thus, not only is optical alignment difficult, but 
also the quantity of unbleached molecules that can contribute to fluorescence recovery is 
limited.  These effects reduce the signal-to-noise ratio and complicate data analysis.  In 
addition, the recovery time associated with a small, focused spot and solute diffusion is 
too rapid for many conventional, simpler instruments.  Despite these challenges, diffusion 
of green fluorescent protein (GFP) has been measured in E. coli with a combination of 
confocal microscopy and bleaching of a significant portion of the cell.137-139    
Fluorescence correlation spectroscopy (FCS) is the other primary method for 
measuring translational diffusion in biological systems.135, 140, 141  FCS suffers in the 
context of small, contained structures, since the size of the illuminated region is on the 
same order of magnitude as the structures.  Consequently, there is only a small population 
of non-illuminated molecules.  Under such conditions, the fluorescence fluctuations can 
be recorded for only a short time before the reservoir of unbleached molecules is depleted 
by photobleaching.  This limitation significantly reduces the signal-to-noise ratio of the 
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fluorescence fluctuation autocorrelation function.  Nonetheless, FCS has been 
successfully employed to measure protein diffusion coefficients in E. coli cells.142  The 
method is limited, however, to low concentrations of fluorescent molecules.  
Continuous fluorescence microphotolysis or continuous photobleaching (CP) is an 
alternate method for characterizing lateral diffusion in biological systems.  In CP, a small 
region of a fluorescently labeled sample is continuously illuminated such that two 
competing processes arise—photobleaching of fluorophores in the illuminated region and 
fluorescence recovery due to diffusion of unbleached fluorophores from surrounding 
regions into the illuminated region.  By monitoring the rate and shape of the fluorescence 
decay, rate constants for the two processes can be determined by fitting to appropriate 
theoretical forms.143, 144  Recently, CP has been used, along with FCS, to measure 
diffusion and compartmentalization in giant unilamellar vesicles and in large living 
cells.145  The results of CP, FCS, spatial imaging, and confocal microscopy have been 
used together to analyze diffusion of intracellular molecules and binding to specific sites 
in cells.146  CP has also been combined with 4Pi microscopy to obtain higher spatial 
resolution.147  Pulsed FRAP, a modification that combines CP and FRAP, has been used 
with confocal microscopy to measure the diffusion coefficients of fluorescent proteins in 
E. coli.148 
Total internal reflection (TIR) has previously been combined with FRAP to 
measure solute diffusion in eukaryotic cells.149  The small penetration depth of the 
evanescent wave results in photobleaching only near the interface.  Since this depth is 
much smaller than the diameter of the laser beam, a one-dimensional geometry can be 
used to simplify the mathematical diffusion model.  The small penetration depth, 
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however, also leads to fast recovery, thus requiring special equipment (e.g., acousto-optic 
modulators).  
Here, we combine total internal reflection and continuous photobleaching to 
demonstrate a new method, TIR-CP, for characterizing the translational diffusion of 
fluorescent molecules contained in structures only slightly larger than classical optical 
resolution.  These structures are deposited on a surface at which a laser beam is internally 
reflected, such that the resulting evanescent intensity illuminates only those fluorescent 
molecules close to the surface.  The sample is continuously photobleached as a function 
of the excitation intensity.  As in CP, two competing processes contribute to the rate and 
shape of fluorescence decay.  At low intensities, the decay is determined by the 
photobleaching rate within the evanescent wave.  At higher intensities, the decay is also 
affected by diffusion of the fluorescent molecules.  Thus, the diffusion coefficient of the 
fluorescent molecules within the small structures can be determined by acquiring data as 
a function of the excitation intensity.  This paper describes the theoretical basis for this 
new method and demonstrates its applicability by measuring the diffusion coefficient of 
GFP in E. coli cells. 
 
4.2 Theory 
4.2.1 Conceptual Basis   
 The notion behind the new method is illustrated in Fig. 1.  Small structures of 
average length L are deposited on a surface at which a laser beam is internally reflected.  
The evanescent intensity decays with distance z from the surface and with a spatial 
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where I0 is the intensity at the interface (z = 0) and at the spot center (x = y = 0).150  The 
characteristic distance for the evanescent wave decay, d, depends on the excitation 
wavelength, the incidence angle, and the refractive indices of the two materials at which 
internal reflection occurs.  Parameters wx and wy are 1/e2 values for the elliptical 
Gaussian shape of the internally reflected beam in the sample plane and depend on the 
initial beam radius as well as the optical parameters used to generate internal reflection.   
The observed sample volume is defined by the depth of the evanescent intensity 
and by a pinhole placed at a back image plane of an optical microscope through which 
the fluorescence is collected.  The pinhole, which is positioned to correspond to the 
center of the illuminated region (x = y = 0), restricts fluorescence observation to a small 
volume so that the collected fluorescence is low enough to be measurable even at 
relatively high excitation intensities.  For the same reason, fluorescence is collected 
though a low numerical aperture objective.  The low numerical aperture does not 
compromise z-axis resolution, which is very thin as defined by the evanescent excitation 
intensity.  The observed area is small enough so that only a few of the small structures are 
present in this area. 
The sample’s fluorescence is monitored as a function of time, t, with t = 0 
corresponding to the onset of illumination.  The time-dependent fluorescence decays to 
zero as molecules within the evanescent wave are photobleached and the reservoir of 
unbleached molecules within the small structure is depleted.  Two competing processes, 
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diffusion and photobleaching, contribute to the rate and shape of fluorescence decay.  At 
low intensities, the decay is determined by the photobleaching rate within the evanescent 
wave.  At high enough intensities, the photobleaching rate is fast enough that the 
diffusion of unbleached molecules into the evanescent wave becomes the rate limiting 
step.  By acquiring data as a function of the excitation intensity, the diffusion coefficient 
of the fluorescent molecules within the small structure is determined.   
4.2.2 Concentration of Unbleached Molecules as a Function of Space and Time   
 The evanescently illuminated area is much larger than the observed area, and the 
pinhole is placed at the center of this illumination.  Since the sample radius (~ 5 µm) is 
much less than wx and wy (22 and 65 µm respectively), the intensity at z = 0 does not 
vary much over the observed area in the x-y plane.  The intensity at z = 0 also does not 
vary significantly as a function of x and y for a given cell because an E. coli cell is 
smaller than the observed area.  Furthermore, the characteristic distance of the evanescent 
wave decay (d ~ 0.1 µm) is much less than the length of a cell in the z-direction (L ~ 2 
µm).  For these reasons, the mathematical problem is approximately one-dimensional in 
space with the key coordinate being z.  The evanescent intensity (Eq. 1) is then 
approximated as  
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and the concentration of unbleached molecules is assumed not to depend on coordinates x 
and y. As a result, an approximate differential equation for the concentration of 
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unbleached molecules is spatially one-dimensional and depends only on the distance 
from the interface, z, and the time, t.  This equation is 
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where U(z,t) is the concentration of unbleached molecules as a function of space and 
time, and D is the diffusion coefficient.  Unlike similar theories,143, 144 Eq. 3 lacks a term 
describing photobleaching, because photobleaching occurs only at or near the illuminated 
surface.  Instead, this process is described by a boundary condition (Eq. 6, see below).  
The initial condition is  
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where C is the total concentration of fluorescent molecules.  One boundary condition is 
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where L is the length of the cell measured from the surface into the solution.  This 
“reflection” condition expresses the notion that the flux across the boundary of the 
structure far from the interface is zero.  The other boundary condition is  
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where κ is a proportionality constant describing the photobleaching propensity with units 
of intensity-1 time-1.151   
The general solution to Eq. 3 is  
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where A, B and β are constants.  Eqs. 5-7 [i.e., the two boundary conditions and the 
general solution] imply that 
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These two equations yield a discrete, countably infinite number of β and x values defined 
by 
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where xn (for n = 1,2,3,…) and c are dimensionless quantities.   
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The values of x1, x2 and x3 (determined numerically) are shown in Fig. 2a as a 
function of c, which is proportional to the excitation intensity, I0 (Eqs. 9).  The values of 
xn have the following properties.  First, (n-1)pi ≤ xn ≤  (2n-1)pi/2.  Second, xn increases 
with c.  At extremely low intensities, c ≈ 0, tan(x1) ≈ 0, and x12 ≈ 0.  At higher intensities, 
tan(x1) ≈ x1 and x12 ≈ c.  As shown in Fig. 3, this approximation is accurate within 10% 
up to c ≤ 0.3.  At even higher intensities, 
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As shown in Fig. 3, this approximation is accurate within 10% up to c ≤ 1.5.  At even 
higher intensities, 
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As shown in Fig. 3, this approximation is accurate within 10% up to c ≤ 2.9.  For 
extremely large intensities, c → ∞ and x1 → pi/2. 
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Eqs. 8 and 9 also imply that 
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Thus (Eqs. 7 and 12), 
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At time zero (Eqs. 4 and 13), 
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Multiplying both sides of Eq. 14 by the factor, 
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and integrating z from zero to L (with Eq. 9) implies that 
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It can be shown in a straightforward manner (with Eq. 9) that each term in Eq. 16 
satisfies Eqs. 3, 5 and 6.  The consistency of Eq. 16 with Eq. 4 can be demonstrated 
numerically. 
4.2.3 Fluorescence Decay During Continuous Photobleaching   
 The observed fluorescence during continuous photobleaching at (x,y) = (0,0), is 
given by (Eqs. 2, 9 and 16) 
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where Q is a proportionality constant.  The initial fluorescence value is (Eqs. 4 and 17) 
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For our experimental conditions, d ≈ 0.1 µm and L ≈ 2.2 µm (see below).  Fig. 2b 
shows the values of f1, f2 and f3 as function of c, for these values of d and L.  As shown, f1 
drops below 0.9 only for c > 0.3.  Thus, for c < 0.3, the fluorescence decay can be 
accurately approximated by a single exponential with rate R1 = D(x1/L)2.  For our 
experimental conditions, c ≤ 2 (see below).  As shown in Fig. 2b, for 0.3 ≤ c ≤ 2, f1 
ranges from 0.9 to 0.6.  Therefore, one might expect that multi-exponential analysis 
would be required for the higher intensities.  For these intensities, however, the second 
rate, R2 = D(x2/L)2, ranges from 5-18 sec-1 (see below), faster than the time resolution of 
our software (50 msec), and contributions to f(t) from terms with n > 1 are negligible.   
Therefore, we evaluate all data as a single exponential with rate, R, where 
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4.2.4 Limits as a Function of Intensity Parameter c   
 When c is small (≈ 0), x12 ≈ 0 (Eq. 9), and Eq. 20 predicts the expected result that 
R ≈ 0 and f(t) ≈ 1 is constant with time.  In other words, for very low intensities, 
photobleaching does not occur.  When c is small but nonzero, tan(x1) ≈ x1, x12 ≈ c and 
Eqs. 9 and 20 predict that 
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The ratio x12/c ≥ 0.9 for c ≤ 0.3 (Fig. 3b).  In this limit, diffusion within the small 
structure is fast enough so that the fluorescence decay rate R does not depend on D but 
only on d, L, κ, and the intensity, as expected.  In addition, R is linear with the intensity.   
For extremely high intensities (c → ∞), xn ≈ (2n-1)pi/2, cos(xn) ≈ 0, cd >> L, c2 >> c.  
Also, d << L.  By using these approximations and the method of partial fractions, one can 
thus show that (Eq. 19)  
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As expected, for high intensities, the fluorescence decay depends only on d, D and L and 
not on the intensity. 
4.2.5 Measurements with Immobilized GFP 
To determine the approximate value of κ, the decay of fluorescence with time was 
measured with purified GFP immobilized on the surface.  In this case, 
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where F(t) is proportional to the density of unbleached GFP on the surface. 
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4.3 Methods 
4.3.1 GFP Expression 
The pAcGFP1 vector (BD BioSciences Clontech, Palo Alto, CA), which contains 
the gene for a nondimerizable GFP152 with 94% identity to EGFP, was transformed into 
E. coli BL21-Gold (DE3) competent cells (Stratagene,  La Jolla, CA) and plated on Luria 
Broth plates containing 1 µg/mL ampicillin (LBAMP).  A starter culture of liquid LBAMP 
was inoculated with a single colony and grown overnight at 37˚C with constant shaking 
at 225 rpm.  This starter culture was used to inoculate (1:25 dilution) 25 mL of fresh 
LBAMP in a 250-mL flask.   Once the optical density at 600 nm was between 0.5 to 0.7, 
the culture was induced with a final concentration of 1-mM isopropyl-β-D-
thiogalactopyranoside (IPTG) and allowed to grow at 37˚C with constant shaking at 225 
rpm.   
4.3.2 GFP Purification 
One L of culture prepared as described above was harvested 4 h after induction by 
centrifugation (Sorvall RC-3B, Sorvall Instruments, Newtown, CT) at 1600 g for 30 min 
at 4˚C. The pellet was resuspended in 30 mL of lysis buffer [ 20-mM Tris (pH 8.0), 200-
mM NaCl, 1-mM EDTA, 1-mM PMSF, 1-mM DNase, 1-mM RNase] and pulse 
sonicated (Branson Ultrasonics, China) at 4˚C (18% amplitude) for two rounds of 5 min 
each.  Cell debris were removed by centrifugation (Sorvall RC-5B with a SS-34 rotor) at 
27000 g.  After dialyzing overnight at 4˚C against 20-mM Tris buffer (pH 8), the sample 
was purified by using anion exchange chromatography (HiLoad 16/10 Q Sepharose, 
AKTA FPLC UPC-900, GE Healthcare, Piscataway, NJ) in 20-mM Tris buffer using a 
linear gradient from 0-M to 1-M NaCl.  The fractions containing GFP were concentrated 
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in an Amicon Ultra MWCO 3,000 centrifugal filter unit (Millipore, Billerica, MA) and 
dialyzed into water.  The protein was further purified by using size exclusion 
chromatography (16/60 superdex 75, GE Healthcare) with water.  The purity was 
confirmed by using SDS-PAGE (18%) with Coomassie Brilliant Blue staining.    
4.3.3 Sample Preparation 
Fused silica slides (1” x 1” x 1 mm, Quartz Scientific, Fairport Harbor, OH) and 
glass microscope slides (3” x 1” x 1 mm, Fisher Scientific, Fair Lawn, NJ) were boiled in 
ICN detergent (MP Biomedicals, Solon, OH) for 10 min, bath-sonicated for 30 min, 
rinsed thoroughly with deionized water, and dried overnight at 160˚C.  The dried slides 
were cleaned in an argon-ion plasma cleaner (PDC-3XG, Harrick Scientific, Ossining, 
NY) for 15 min at 25˚C immediately prior to use.  The fused silica slides were pretreated 
with a 0.01% (w/v) poly-L-lysine solution (Sigma-Aldrich, St. Louis, MO) for 15 min, 
rinsed with minimal media [7.6-mM (NH4)2SO4, 60-mM K2HPO4, 2-mM MgSO4, 20-µM 
FeSO4, 1-mM EDTA (pH 6.8)], and attached to a microscope slide with double-sided 
tape (Part No. 021200-64988, 3M Corp, St. Paul, MN) to form a sandwich.  For osmotic 
stress measurements, the minimal media rinse contained 250-mM sorbitol (0.390 
osmolal).  The samples, which consisted of either bacterial cultures collected 3 h after 
induction or 2-µM purified GFP containing 5-mg/mL bovine serum albumin (Sigma-
Aldrich, St. Louis, MO), were injected into the sandwiches.  After incubating for 30 min 
at 25˚C, the sample chamber was rinsed with minimal media and sealed with vacuum 
grease. 
 
 
 129
4.3.4 Total Internal Reflection (TIR) Fluorescence Microscopy  
 Through-prism total internal reflection bleaching experiments were carried out on 
an instrument consisting of an inverted microscope (Zeiss Axiovert 35, Thornwood, NY), 
an argon ion-laser (Innova 90-3; Coherent, Palo Alto, CA), and a single-photon counting 
photomultiplier (RCA C31034A, Lancaster, PA).  The instrument was controlled with an 
in-house LabVIEW program and DAQ board (PCI-MIO-16XE-50, Texas Instruments, 
Austin, TX).  Experiments were conducted at 25oC by using an excitation wavelength of 
488 nm and a laser power ≤ 500 mW.  To achieve optimal excitation intensity without 
overloading the detector, a 100-µm diameter pinhole was inserted in a back intermediate 
image plane of the microscope and aligned to correspond with the center of the TIR 
illumination.  Polarization paper (25% transmission, Edmund Optics, NT54-795) was 
also inserted after the dichroic mirror and barrier filter, but before the detector, to 
attenuate the signal.  The bleaching intensity was varied by inserting neutral density 
filters in the beam path prior to excitation. The fluorescence decay was collected with a 
10x, 0.25 numerical aperture objective for up to 90 sec.   
4.3.5 Size of Evanescent Illumination 
TIR was generated on a fused silica/microscope slide sandwich containing a 1-
µM solution of Alexa Fluor 488 carboxylic acid, tetrafluorophenyl ester (Molecular 
Probes/Invitrogen, Carlsbad, CA) as described above.  Five images of the TIR spot were 
collected with an AT200 CCD camera and software (Photometrics, Tucson, AZ).  To 
determine wx and  wy (Eq. 1), slices of the images with y = 0 or x = 0 were converted to 
pixel intensities W(x) or W(y) with the Photometrics software and plotted as a function of 
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distance.  The pixel dimension (0.87 µm) was determined by imaging a graticule.  The 
data were fit in Sigma Plot (Systat Software Inc., San Jose, CA) to 
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with W0, wx( or wy), and γ (the background) as free parameters.  
4.3.6 Intensity Values   
For a given incident laser power, P, at z = 0 (Eq. 1), 
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The value of I0 was determined as 
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by using Eq. 27 with the known values of P, wx and wy. 
4.3.7 Cell Length 
Samples were prepared as described above except that 5-µg/mL FM1-43 
membrane stain (Molecular Probes/Invitrogen, Carlsbad, CA) was added to the samples 
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and No. 1.5 glass coverslips (Fischer Scientific, Fair Lawn, NJ) were used in place of the 
fused silica slides.  The cells were imaged on a Zeiss 510 scanning confocal inverted 
microscope (Carl Zeiss, Thornwood, NY) with a 63x, 1.4 NA oil-immersion objective, a 
65-µm pinhole, and an excitation wavelength of 488 nm.  Sixteen 36.6-µm x 36.6-µm 
images were collected in the x-y plane by moving away from the coverslip in 0.2-µm 
increments.  From these images, the maximum lengths of 110 cells in the z-direction 
were determined and averaged, yielding L = 2.2 ± 0.5 µm.  Repeating this process for 
107 sorbitol-treated cells gave L = 1.8 ± 0.5 µm. 
4.3.8 Data Analysis 
Fluorescence decays were fit to the following function by using Sigma Plot:  
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with F(0), R and φ (the background) as the free parameters.  At least three (and often 
more) decay curves were collected for each I0 and the R values averaged.  Three 
complete data sets were acquired.  The average values of R as a function of I0, for the 
three data sets, were fit to Eq. 20 with x12 given by Eq. 11 and c given by Eq. 9.  In these 
fits, L was fixed to 2.2 µm (see above) and the free parameters were D and b = κd.  The 
process was repeated for the sorbitol-treated cells using L =1.8 µm (see above). 
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4.4. Results  
4.4.1 Size of Evanescent Illumination in the x-y Plane and I0 Values   
To determine the values of wx and wy (Eq. 1), five images of fused silica slides 
coated with Alexa Fluor 488 were acquired using an imaging detector (see Methods).  As 
shown in Fig. 4a, the lateral intensity profile of the evanescent illumination appeared to 
be of an elliptical Gaussian shape.150  Images like those shown in Fig. 4a report the value 
of I(x,y,0) (Eqs. 1, 24, 25 and 26).  The pixel intensities as a function of distance along 
the x-axis (y = 0) and along the y-axis (x = 0) were plotted for each image.  These data 
were fit to Eqs. 24 and 25 and gave Gaussian-shaped curves as shown by the quality of 
the fits (Fig. 4b).  The averages of the best-fit values were wx = 22.4 ± 0.5 µm and wy = 
65.0 ± 0.4 µm.  Excitation intensities I0 were then determined by using Eq. 27. 
4.4.2 Cell Length 
The cell length L was measured by using confocal microscopy and E. coli treated 
with the membrane stain FM1-43.  Sixteen 36.6-µm by 36.6-µm images were collected in 
the x-y plane by moving away from the coverslip to which the E. coli were adhered in 
0.2-µm increments.  Fig. 5 shows two slices in the x-y plane of cells at different distances 
from the interface.  The majority of the cells were ellipsoidal and had their major axis 
parallel to the interface. The circles in Fig. 5a are cells attached perpendicular to the 
interface and thus extend further into the solution.  This result is apparent in Fig. 5b (the 
slice farther from the interface) where the ellipsoidal shaped cells have begun to fade, 
while the fluorescence of the circular cells remains strong.  These images also confirmed 
that the cells were immobilized by the poly-L-lysine and that the GFP was contained 
within the cells.  By averaging the maximum length in the z-direction of 110 cells in 
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different spatial orientations, L was determined to be 2.2 ± 0.5 µm, which is consistent 
with the literature value.153, 154  Repeating this process for 107 sorbitol-treated cells gave 
L = 1.8 ± 0.5 µm.  With > 99% confidence (student’s t-test), the sorbitol-treated cells are 
shorter than non-treated cellst, since osmotic stress shrinks the cells.155 
4.4.3 Photobleaching Propensity 
The propensity for photobleaching, described by the parameter κ (Eqs. 6, 9 and 
23), was measured by monitoring the evanescently excited fluorescence decay of pure 
GFP immobilized on fused silica slides, as a function of time and excitation intensity.  
Fig. 6a shows three representative decay curves and the corresponding best fits to Eq. 28.  
At very low excitation intensities, bleaching was almost negligible.  As the laser power 
was increased, so did the initial fluorescence intensity and the decay rate.  As shown in 
Fig. 6b, the decay rate was linearly proportional to the excitation intensity.  The slope of 
this line yields a κ (for immobilized GFP) of 0.21 ± 0.01 µm2µW-1sec-1.       
4.4.4 Diffusion Coefficient of GFP in E. coli  
Three complete data sets for the intensity-dependent, evanescently-excited 
fluorescence decays of GFP in E. coli were acquired.  Fig. 7 shows examples of typical 
decay curves collected from continuous photobleaching of the cells close to the adherent 
surface.  For each decay curve, the decay rate constant, R, was determined by fitting the 
data to Eq. 28 with the intensity, I0, determined as described above.  As expected, both 
F(0) and R increased with I0.  For each data set, the average values of R as a function of 
I0 were then fit to Eq. 20 with L = 2.2 µm, x12 given by Eq. 11, and c given by Eq. 9.  The 
free parameters were D and b = κd.  A representative plot showing the experimental 
values and their best fits to this theoretical form is shown in Fig. 8.  The best fit values of 
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the free parameters for the three data sets were averaged to give D = 6.3 ± 1.1 µm2sec-1 
and b = 0.026 ± 0.001 µm3µW-1sec-1.   In all cases, the parameter c was calculated by 
using Eq. 9 and the best-fit values of b and D along with the known values of L and I0.  
The maximum value of c was 2.0, validating the use of single-exponential fits and Eq. 11 
(see above).   
The diffusion coefficient obtained by TIR-CP, 6.3 ± 1.1 µm2sec-1, agrees well 
with that measured by confocal-FRAP on the same system in our laborartory (data not 
shown).  The measured coefficient also agrees well with literature values for GFP 
diffusion in E. coli cells.  The most commonly referenced value137, 7.7 ± 2.5 µm2 s–1, was 
obtained by using confocal FRAP.  Similar studies found D = 6.1 ± 2.4 µm2 s–1 138 and 
3.2 µm2 s–1.148  Other groups have measured diffusion coefficients of GFP fusion proteins 
in E. coli that are also consistent with our value, such as TorA-GFP (30 kDa), 9.0 ± 2.1 
µm2 s–1 ;139  cMBP-GFP (72 kDa), 2.5 ± 0.6 µm2 s–1;137 and CheY-GFP (40 kDa), 4.6 ± 
0.8 µm2 s–1.142 
The b parameter from the fits contains information about the propensity for GFP 
to photobleach, since b = κd.  For our experimental conditions, d ≈ 0.1 µm 156 and b = 
0.026 ± 0.001 µm3µW-1sec-1.  Taken together, these values yield κ ≈ 0.26 µm2µW-1sec-1, 
which is comparable to the value (0.21 ± 0.01 µm2µW-1sec-1) for the immobilized GFP 
(Fig. 6).   
Several GFP variants have been reported to reversibly photobleach.149, 157  To 
assess the degree of reversible photobleaching that might be occurring, confocal 
microscopy was used to bleach GFP throughout entire E coli cells and to monitor the 
intracellular fluorescence over time.  Post-bleach fluorescence recovery was not 
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observed, indicating that GFP is irreversibly photobleached over the time scale of the 
experiment (data not shown). 
4.4.5 Effects of Osmotic Shock  
To further confirm the validity of the new technique, we measured GFP diffusion 
in sorbitol-treated cells.  Sorbitol, and other forms of osmotic shock, increase the 
intracellular concentration of macromolecules, which significantly decreases protein 
mobility.158  Data from confocal FRAP experiments show that GFP diffusion in E. coli 
cells decreases to 0.94 ± 0.55 µm2sec-1 in 392 milliosmolal solution.138  A similar study 
reported a diffusion coefficient of 1.8 µm2sec-1 in a 370 milliosmolal buffer.148  For TIR-
CP experiments, three complete data sets were collected for GFP in E. coli exposed to a 
390 milliosmolal sorbitol buffer and analyzed as described above.  The diffusion 
coefficient decreased from 6.3 ± 1.1 µm2sec-1, to 3.05 ± 1.0 µm2sec-1in a sorbitol buffer.    
 
4.5 Discussion 
As shown here, total internal reflection illumination with continuous 
photobleaching (TIR-CP) can be used to monitor the translational mobility of fluorescent 
molecules within small structures that are only slightly larger than optical resolution.   
The structures are deposited on a surface such that the evanescent wave generated by 
internal reflection continuously photobleaches only those fluorescent molecules very near 
the surface (Fig. 1).  The resulting fluorescence decay curves depend on two competing 
processes: photobleaching and diffusion.  At low excitation intensities, the propensity for 
photobleaching determines the rate and shape of the fluorescence decay curves.  At 
higher excitation intensities, the diffusion rate of the fluorescent molecules across the 
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length of the small structure also affects the fluorescence decay curves.  By examining 
the fluorescence decay as a function of the excitation intensity, the diffusion coefficient 
of the fluorescent molecules within the small structures can be determined.  This new 
method was demonstrated by measuring the diffusion coefficient of GFP in E. coli.  The 
measured diffusion coefficient agreed with those measured by different methods.137-139, 
142, 148
  In addition, data were acquired for GFP in E. coli subjected to an osmotically 
stressed environment and analysis of these data reported lower GFP diffusion 
coefficients.  This result is also consistent with data obtained by different methods.138, 148   
As described in the Introduction, other techniques have also been developed for 
examining molecular mobility in small biological structures, particularly E. coli.  The 
most well developed of these methods is confocal-FRAP.  Two advantages of TIR-CP as 
compared to confocal-FRAP are that the evanescent illumination confines 
photobleaching to a smaller fraction of the E. coli volume and the simplicity of the 
required instrumentation.  TIR-CP also avoids the complication of aligning a very small 
focused laser beam within the small structure of interest (e.g., E. coli).  However, for both 
methods, either the shape of the E. coli must be approximated to obtain analytical 
theoretical forms for the exact geometry of a given E. coli must be measured and used in 
numerical simulations.   
Confocal-FRAP monitors diffusion on a cell-by-cell basis, and, although data 
analysis is somewhat tedious, this method can provide diffusion coefficient histograms 
and correlations of intracellular molecular mobility with other cellular characteristics.  In 
TIR-CP as described here, a few cells rather than one are in the observed volume.  
However, the possibility exists of generalizing TIR-CP by using a fast EMCCD camera 
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and subsequent imaging.  Because the evanescent intensity varies as a function of 
position (Fig 4), the entire range of intensity-dependent decay curves could be acquired 
from a single time-dependent image sequence.  Given a dilute enough density of adherent 
cells, this method might also provide histograms of apparent diffusion coefficients, as 
well as correlations of mobility with other cellular properties. 
A third method, TIR-FRAP, has also been used to measure the cytoplasmic 
mobility of fluorescent molecules close to the inner leaflet of membranes of surface 
adherent, large eukaryotic cells.149  TIR-FRAP has potential for being generalized to 
small cells such as E. coli.  TIR has also been combined with FCS to monitor 
translational mobility close to surface-adsorbed model membranes.159  TIR-FCS could, in 
principle, measure membrane-local diffusion coefficients in small structures.  Such 
potential TIR-FCS measurements, however, would suffer because the pool of unbleached 
molecules is limited in small structures.  In addition, it has been demonstrated that the 
apparent diffusion coefficients of proteins close to membrane surfaces is significantly 
reduced due to hydrodynamic effects.160  Such potential measurements, therefore, would 
not directly report the overall apparent diffusion coefficient of fluorescent molecules 
throughout the structure. 
In this paper we have used TIR-CP to examine protein diffusion in E. coli.  This 
new method may also be applicable to other small biological structures such as 
phospholipid vesicles, isolated synaptic vesicles, and isolated organelles (e.g., 
mitochondria).  Furthermore, the technique shows promise for use over a wide range of 
protein concentrations.  While FCS is strictly limited to very low concentrations, 
confocal-FRAP becomes challenging at low concentrations due to poor signal-to-noise.  
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In contrast, TIR-CP is applicable both to low and high concentrations, because of the 
range of excitation intensities available.  Analysis at these concentrations may be 
important as it has been reported that the level of protein expression in E. coli may affect 
the protein diffusion coefficient.137  In addition, controlling the level of one protein while 
monitoring the diffusion coefficient of another protein might reveal not only 
concentration-dependent diffusion, but also provide insight about protein-protein 
interactions.     
4.6 Acknowledgements 
 We thank Michael Chua of the UNC Microscopy Facility for assistance with 
confocal microscopy and Xiang Wang of UNC Chemistry for assistance with imaging the 
evanescent illumination.   This work was supported by NSF Grants MCB-0641087 
(NLT) and MCB-0516547 (GJP), an NSF Graduate Fellowship Award 2006037054 
(KMS), and by NIH Director’s Pioneer Award DP10D783 (GJP). 
 139
 
 
 
Figure 4.1 Through-Prism Total Internal Reflection with Continuous 
Photobleaching (TIR-CP).    (a) Schematic of the instrumentation:  PMT, 
photomultiplier tube; BF, barrier filter; DM, dichroic mirror; PP, polarization paper 
(see Methods); ND, neutral density filter.  (b) A fused silica prism is optically coupled 
with glycerol to a sandwich made from fused silica and microscope slides. (c)  Small 
structures that extend a distance L into the solution are attached to the lower surface of 
the fused silica slide.  A laser beam is internally reflected at the interface of the fused 
silica slide and the internal solution of the sandwich to create an evanescent field 
whose intensity decays exponentially with distance, z, from the interface.  The 
characteristic distance of this decay, d, is much smaller than L.  Molecules contained 
within the small structure do not fluoresce (grey circles) until they diffuse into the 
surface-associated evanescent field.   (d)  Eventually, the fluorescent molecules (green 
circles) are permanently bleached (black circles) by exposure to the evanescent field.  
At low excitation intensities, the decay of evanescently excited fluorescence with time 
is dominated by the propensity for photobleaching.  At high excitation intensities, the 
decay of fluorescence with time is dominated by diffusion through the length of the 
small structure.   
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Figure 4.2 Parameters xn and fn.  Fluorescence decay during continuous 
photobleaching is described by an infinite sum of exponentials with rates D(xn/L)2, 
where D is the diffusion coefficient and L is the cell length (Eqs. 9 and 19).  The 
parameters xn are a discrete, countably-infinite set of values that are determined by the 
value of the parameter c.  Parameter c depends on experimental conditions (D, L, the 
depth of the evanescent wave d, and the bleaching propensity κ).  Most importantly, c 
is proportional to the excitation intensity I0.  The parameters fn are amplitudes 
associated with the different exponentially decaying terms and are defined, in general, 
by the values of c, L, d and xn.  (a)  The values of x1 (■), x2 (●) and x3 (▲) were 
calculated numerically as a function of c by using Eq. 9.  (b) The values of f1 (■), f2 
(●) and f3 (▲) were calculated by using Eq. 19 with L = 2.2 µm and d = 0.1 µm.  At 
low c values, the first amplitude, f1 is much larger than the others and the fluorescence 
decay can be approximated as a single exponential with rate D(x1/L)2.  In addition, for 
many experimental conditions, the terms associated with rates having n > 1 decay too 
rapidly to affect the observed fluorescence decay. 
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Figure 4.3 Accuracy of x12 Approximations.  Parameters xn and c are described in 
the caption to Fig. 2.  (a) This plot shows x12 approximated as c (- · - ·) (see text), as 
Eq. 10 (- - -) and as Eq. 11  (—) compared with the numerically determined values (•) 
as a function of the parameter c (Eq. 9).   (b) This plot shows the corresponding ratios 
of the actual x12 values divided by the approximations as a function of c, such that 
values close to one represent an accurate approximation.  As shown, Eq. 11 is a good 
approximation for the experimental conditions used in this work (c ≤ 2).   
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Figure 4.4 Spatial Profile of the Evanescent Illumination in the x-y Plane.   
(a) Evanescently excited Alexa Fluor 488 dye was non-specifically adsorbed to the 
surface of fused silica.  The circle indicates the observed area within the pinhole.   
(b) Data were obtained by slicing images with x = 0 or  y = 0 and plotting the 
corresponding pixel intensities as a function of distance.  A representative slice with  
y = 0 and its best fit to Eq. 24 is also shown.  
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Figure 4.5 Cell Length, L.  E. coli cells expressing GFP were stained with FM1-43 
dye and attached to poly-L-lysine coated coverslips.  Using a confocal microscope, 
images were collected in the x-y plane by moving away from the coverslip in 0.2-µm 
increments.  The images are 36.6 µm x 36.6 µm and were collected (a) 1.4 µm and (b) 
2.4 µm from the coverslip.   
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Figure 4.6 Photobleaching Propensity for Immobilized GFP.  (a) Representative 
evanescently excited fluorescence decay curves are shown for purified GFP immobilized on 
fused silica.  The excitation intensities I0 were 0.9 (□), 4.3 (○), and 8.5 (▲) µW/µm2.  The 
solid curves show the best fits of the data to Eq. 28.  (b) The average fluorescence decay rate 
R is a linear function of the excitation intensity, I0. 
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Figure 4.7 Representative Evanescently Excited Fluorescence Decay Curves for 
GFP in E. coli Cells.  The excitation intensities were 5 (◊), 35 (▲), 87 (○), and 220 
(■) µW/ µm2.  The solid curves show the best fit of the data to Eq. 28.   
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Figure 4.8 Diffusion Coefficient  D and Parameter b for GFP in E. coli.  Plot 
shows data from one data set in which the measured decay rates R are plotted as a 
function of the excitation intensities, I0.  Rates represent an average of at least three 
measurements with uncertainties given as standard deviations.  The line shows the best 
fit to Eq. 20 with x12 given by Eq. 11, L fixed at 2.2 µm, and free parameters D and  
b = dκ.  In this case, D = 6.3 µm2sec-1, b = 0.025 µm3µW-1sec-1, the maximum value of 
c = 2.0 (Eq. 9), and correlation coefficient was 0.93. 
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